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ABSTRACT 
 
Mitochondria contain a low-molecular-mass (LMM) pool of weakly bound iron 
complexes, called the labile iron pool (LIP). Although its composition and biological 
function remain largely uncharacterized, the LIP has been implicated in cellular iron 
metabolism and disease pathogenesis. In this dissertation, results obtained from 
Mössbauer, EPR, and UV-Vis studies were integrated with LC-ICP-MS data to investigate 
the chemical nature of the mitochondrial LIP. 
LMM Fe, Mn, Cu, Zn, and Co complexes were detected in yeast and mammalian 
mitochondria. Such complexes were reproducibly observed and hypothesized to metalate 
mitochondrial apo-metalloproteins. The approximate mass of each complex was estimated 
along with its mitochondrial concentration. The predominant LMM Fe species detected in 
mitochondria had a mass of ~580 Da (called Fe580) and was present in both yeast and 
mammalian mitochondria. Increasing the Fe concentration in the medium increased the 
intensity of Fe580. Interestingly, the mitochondrial concentration of Fe580 was ~100 µM, 
which was consistent with previous estimates of the mitochondrial LIP. Thus, Fe580 was 
hypothesized as the cytosolic iron species that is imported into mitochondria to form the 
LIP. Treatment with metal chelators demonstrated that Fe580 was labile. 
A yeast strain lacking mitochondrial Fe importers, Mrs3/4, was characterized using 
biophysical and bioanalytical methods (DD). Respiring Fe-deficient DD cells exhibited a 
“slow-growth” phenotype that was ameliorated under Fe-sufficient conditions. DD cells 
accumulated more Fe than wild-type (WT) cells, even under Fe-sufficient conditions, 
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indicating Fe dysregulation. DD cells accumulated NHHS FeII and FeIII in the cytosol and 
vacuoles, respectively. Fe-deficient DD mitochondria accumulated FeIII oxyhydroxide 
nanoparticles and were devoid of central doublet ([Fe4S4]2+ and LS FeII hemes), whereas 
Fe-sufficient DD mitochondria contained comparable levels of central doublet but less 
NHHS FeII relative to WT. This suggested the mitochondrial NHHS FeII pool was reduced 
in Fe-sufficient DD cells. Fe580 was absent in Fe-deficient DD mitochondria but present 
under Fe-sufficient conditions. Two candidate masses {664.46 and 665.46 amu} and 
{685.39 and 686.39 amu} were determined for Fe580. Viewed comprehensively, this study 
provides strong evidence that the mitochondrial NHHS FeII pool is composed 
predominantly of Fe580 and that the size of this pool controls cellular Fe homeostasis. 
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NOMENCLATURE 
 
AD Alzheimer’s disease 
ADP adenine diphosphate 
Afg3 ATPase family gene 3 
AMP adenine monophosphate 
Atm1 ABC transporter of the mitochondrion 
ATP adenine triphosphate 
BPS Bathophenanthroline disulfonate 
Ccc1 Fe transport protein on the vacuolar membrane 
CIA cytosolic iron-sulfur cluster assembly 
CD central doublet 
CuL a 13 kDa nonproteinaceous Cu species found in mitochondria 
CV column-volume 
DDDI double-distilled and deionized 
DTT dithiothreitol 
EGTA ethylene glycol tetraacetic acid 
ERV1 essential for respiration and viability 
ESI-MS electrospray ionization mass spectrometry 
EPR electron paramagnetic resonance 
Fecyt cytosolic iron 
Femed iron contained in the growth medium 
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FTS flow-through solution 
GSH glutathione (reduced) 
GSSG glutathione disulfide (oxidized) 
HMM high-molecular-mass (> 10 kDa) 
Hot13 helper of Tim 
HS high-spin 
ICP-MS inductively coupled plasma mass spectrometry 
IM inner membrane of mitochondria 
IMS intermembrane space 
ISC iron-sulfur cluster 
LC liquid chromatography 
LC-ICP-MS a system consisting of an LC interfaced online to an ICP-MS 
LIP labile iron pool 
LMM low-molecular-mass (< 10 kDa) 
LMP labile metal pool 
LS low-spin 
mARC1/2 mitochondrial amidoxime reducing components isoforms 1 and 2 
MAS1/2 b and a subunits of MPP 
Mia40 mitochondrial intermembrane space import and assembly 
MB Mössbauer 
MCF mitochondrial carrier family 
Moco molybdopterin cofactor 
  xi 
MPP mitochondrial processing peptidase 
Mrs3/4 Mrs3 and Mrs4 (two homologous Fe importers on the IM) 
MUT methyl-malonyl-CoA 
NP ferric oxyhydroxide nanoparticles 
NHHS non-heme high-spin 
OD600 optical density measured at 600 nm 
OM outer membrane of mitochondria 
PD Parkinson’s disease 
Phen 1,10-phenanthroline 
PLP pyridoxal 5’-phosphate 
PMSF phenylmethanesulfonylfluoride 
RT room temperature 
ROS reactive oxygen species 
SEC size-exclusion chromatography 
SME soluble mitochondrial extract 
SO sulfite oxidase 
Sod superoxide dismutase 
Tim translocase of the inner membrane 
Tom translocase of the outer membrane 
UV-Vis ultraviolet-visible 
VDAC voltage-dependent anion channel 
V0 void volume 
  xii 
Ve elution volume 
WT wild-type 
WT1BPS Wild-type cells grown on 25 µM BPS + 1 µM Fe 
WT1 Wild-type cells grown on 1 µM Fe 
WT10 Wild-type cells grown on 1 µM Fe 
WT40 Wild-type cells grown on 1 µM Fe 
YL0 yeast, low OD600, injected following preparation (t = 0) 
YL5 yeast, low OD600, injected 5 days after preparation (t = 5) 
YH0 yeast, high OD600, injected following preparation (t = 0) 
YH5 yeast, high OD600, injected 5 days after preparation (t = 5) 
YRL0 yeast, respiring, low OD600, injected following preparation (t = 0) 
YPD standard rich growth medium for yeast containing glucose 
YPAD rich growth medium for yeast containing glucose and adenine 
a exponential growth rate 
d isomer shift 
DEQ quadrupole splitting 
DD Mrs3/4 double-deletion mutant yeast strain 
DD1BPS Mrs3/4 double-deletion cells grown on 25 µM BPS + 1 µM Fe 
DD1 Mrs3/4 double-deletion cells grown on 1 µM Fe 
DD10 Mrs3/4 double-deletion cells grown on 10 µM Fe 
DD40 Mrs3/4 double-deletion cells grown on 40 µM Fe 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW* 
 
Mitochondria as “Hubs” of Metal Metabolism 
Mitochondria are fundamental organelles found in almost all eukaryotic cells. In 
addition to their prominent and well-established role in cellular energy transduction, 
mitochondria serve as major “traffic hubs” for an array of transition metals. Redox-active 
transition metals, including iron, copper, manganese, cobalt, and molybdenum (as well as 
redox-inactive zinc) are typically bound at the active sites of enzymes where they help 
catalyze diverse biochemical reactions. Their excellent catalytic properties derive from (a) 
the availability of d orbitals to participate in redox chemistry and bonding, (b) the 
abundance of coordination sites that can accommodate and orient multiple substrates, and 
(c) the weakness of coordinate bonds that promotes facile binding and release of 
substrates, intermediates, and products. Metals also serve as integral structural and 
functional components in a large class of proteins, called metalloproteins. 
A significant number of metalloproteins and enzymes are distributed throughout 
the mitochondria. These organelles contain respiratory complexes and respiration-related 
proteins that are packed with iron-sulfur clusters (ISCs) and heme centers. In fact, both 
ISC assembly and the Fe insertion step of heme biosynthesis occur within this subcellular 
                                                
* Adapted with permission from Paul A. Lindahl and Michael J. Moore (2016) Labile 
Low-Molecular-Mass Metal Complexes in Mitochondria: Trials and Tribulations of a 
Burgeoning Field, Biochemistry 55, 4140–4153. Copyright 2016 American Chemical 
Society. 
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compartment.1 Mitochondria house copper-containing proteins such as cytochrome c 
oxidase, Cu/Zn superoxide dismutase (Cu/Zn Sod1), and the many chaperones that shuttle 
Cu to these two enzymes during their assembly.2,3 Mitochondria possess an important 
manganese-containing enzyme, namely superoxide dismutase (MnSod2).4 Mammalian 
mitochondria also contain arginase II, a dimanganese enzyme.5,6 Approximately 15% of 
the cobalt in mammalian cells is localized to mitochondria,7 most of which is bound at the 
active site of methyl-malonyl-CoA mutase (MUT). A small portion of mitochondrial Co 
is coordinated to trafficking proteins that install adenosylcobalamin into apo-MUT. 
Mammalian mitochondria contain three molybdenum metalloenzymes, including sulfite 
oxidase and mitochondrial amidoxime reducing component isoforms 1 and 2 (mARC1 
and -2, respectively).8 Mitochondria house numerous zinc-containing proteins, the best 
known of which include Cu/Zn Sod1 and cytochrome c oxidase.3,9,10 In yeast, alcohol 
dehydrogenase III (ADH3) is a Zn metalloenzyme that is involved in NAD(P)H redox 
balance and the ethanol-acetaldehyde shuttle under anaerobic conditions.11,12 Zn-bound 
MST1 is a mitochondrial threonyl-tRNA synthetase that aminoacylates two tRNAs.25 D-
lactate dehydrogenase is a Zn-containing enzyme that catalyzes the oxidation of lactate to 
pyruvate,13 and the Zn-dependent enzyme glyoxalase II promotes the hydrolysis of S-D-
lactoylglutathione into glutathione and D-lactate within the matrix.14 a-Isopropylmalate 
synthase I and II are Zn enzymes that catalyze the first step of leucine biosynthesis.15 Both 
of these enzymes are regulated by the Zn-dependent reversible inactivation by coenzyme 
A, which links leucine biosynthesis to mitochondrial energy metabolism.16 Zn-bound 
MST1 is a mitochondrial threonyl-tRNA synthetase that aminoacylates two tRNAs.17 
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Virtually all mitochondrial proteins are encoded in the nucleus, synthesized on 
ribosomes in the cytosol, and imported into mitochondria via protein translocation 
machines.18,19 Many nascent unfolded proteins are threaded through the TOM (translocase 
of the outer mitochondrial membrane) complex and then sorted according to their final 
intramitochondrial destinations.20 The imported proteins that are targeted for the matrix 
typically contain a presequence that is cleaved by mitochondrial processing peptidase 
(MPP), a reaction that triggers protein folding. Numerous Zn-containing metalloproteases 
are involved in these processes. Mas1/2 is the MPP metalloendopeptidase that cleaves 
presequences from the majority of imported mitochondrial proteins.21 Oct1 is a matrix 
intermediate metallopeptidase that cleaves destabilizing N-terminal residues of some 
proteins after cleavage by MPP.22 Afg3 is a subunit of the ATP-dependent m-AAA 
metalloprotease found in the inner membrane of mitochondria (IM).21 Yme1 is the Zn-
containing catalytic subunit of the i-AAA metalloprotease complex; this IM enzyme helps 
degrade unfolded or misfolded mitochondrial proteins.23 Cym1 and Prd1 are lysine-
specific metalloproteases that degrade proteins and presequences.22 Other Zn-containing 
proteins are involved in protein import or folding. ZIM17 (zinc finger motif protein of 17 
kDa) helps import and fold proteins entering the matrix.24 MDJ1 stimulates the ATPase 
activity of the Hsp70 protein Ssc1p and helps fold or refold proteins in the matrix. This 
Zn-containing protein helps form mitochondrial nucleoids and maintain mtDNA 
stability.25 Zn-containing TIM9 and TIM10 (translocases of the inner mitochondrial 
membrane) form a hexameric complex in the intermembrane space (IMS) that delivers 
hydrophobic proteins to the TIM22 complex for insertion into the IM.26 Binding of Zn to 
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Cys residues stabilizes these proteins and prevents oxidation to disulfides. Newly imported 
IMS proteins TIM10, TIM12, and TIM13 bind Zn and interact with Mia40 for folding and 
oxidation.27 Mia40 is an IMS protein that coordinates Zn.28 The Zn bound to these small 
TIM proteins may be transferred onto Mia40 during oxidation (a process that traps these 
proteins in the IMS). Zn bound to reduced Mia40 may inhibit its reoxidation by Erv1. IMS 
protein Hot13 may remove Zn from Mia40 to aid in its reoxidation.29 However, the small 
TIM proteins may not be importable with Zn bound, suggesting an alternative role for 
Hot13.30 
The folding of nascent apo-metalloproteins within the matrix is typically 
accompanied by the incorporation of metal ions or centers. The question is how these 
metals reach the matrix. Metals en route to the matrix must first pass across the outer 
membrane of mitochondria (OM), which may occur via simple diffusion through the 
hydrophilic pores of VDACs (voltage-dependent anion channels). VDACs, also known as 
porins, are integral membrane proteins that constitute ~30% of the OM surface area,31 
creating pores with diameters of 2 – 3 nm.32 Metabolites with masses of less than ~5000 
Da, including water, ions, ATP/ADP, and perhaps metal species, can freely diffuse 
through VDACs, whereas import of larger compounds is regulated. In contrast to the OM, 
the IM is notoriously impermeable to most small metabolites and ions, such that even 
protons are unable to diffuse across it under normal conditions. In all likelihood, metal 
ions are translocated from the IMS into the matrix by specific transport proteins embedded 
in the IM.3,33 Similar issues arise for metalloproteins targeted to other mitochondrial 
locations; specific metal complexes must be used, and there must be distinct transport 
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systems that guide them to the appropriate location within the organelle so that they can 
metalate their targets. Thus, metalation reactions in the IMS are likely different from those 
in the matrix, which may be especially important for Zn and Cu trafficking. 
 
Labile Metal Pools within Mitochondria 
The discovery of metallochaperone proteins in the 1990s suggested that upon 
entering the cell, transition metals are trafficked to their respective target proteins by being 
passed from one metallochaperone to another, like a baton handed from one runner to the 
next in a relay race. In addition to metallochaperones, cells utilize a variety of proteins 
that modulate metal homeostasis and delivery to apoproteins, including metal storage 
proteins,34 metal-sensing proteins,35 and metal-inserting enzymes.36 Thus, aqueous metal 
complexes (sometimes erroneously called “free” metal ions) or other non-protein-bound 
metal complexes were not thought to exist in cells.37-39 However, this view has evolved 
over the years because of the detection of labile metal pools (LMPs) within cells and 
mitochondria. 
Labile metal pools are defined as collections of endogenous metal ions bound 
weakly to various low-affinity nonproteinaceous ligands. Such pools have been termed 
“bioavailable pools,” “chelatable pools,” or “exchangeable pools” (often interchangeably) 
throughout the literature. The first documented mention of a labile metal pool appeared in 
a 1949 report by Greenburg and Wintrobe,40 and was further described by Jacobs,41 as a 
transient intracellular iron pool that exists as a metabolic intermediate between iron uptake 
from the extracellular environment and iron incorporation into iron-containing 
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compounds. Since then, labile pools of iron,42 zinc,43 and copper44 have been identified in 
mitochondria. Mitochondrial LMPs are thought to exist because of the continuous demand 
for metals to be available for the biosynthesis of metal-containing proteins and enzymes, 
inducing metal ion uptake from the cytosol into the matrix compartment. The 
concentration of the metals in such pools is relatively low (micromolar to nanomolar 
range), accounting for only a minor fraction of the total mitochondrial metal content. As 
such, the majority of metals in mitochondria are tightly associated with metalloproteins. 
Concentrations of LMPs may be important in regulating cellular metal homeostasis via 
metal-sensing proteins under metal-deficient and -sufficient states.35 
Many of the details concerning the nature, structural composition, and 
physiological role of LMPs remain obscure. As a result, the number of metal compounds 
constituting LMPs as well as the identities of endogenous ligands are unknown. Although 
their exact cellular functions are uncharacterized, LMPs likely participate in trafficking, 
regulation, signaling, and/or storage of metal ions.45,46 Given their lability (and low 
concentrations in mitochondria), determining the structures and functions of the metal 
complexes that compose these pools has been, and continues to be, a considerable 
challenge. 
 
Evaluation of Current Research Strategies 
Two general strategies, in combination with genetic and spectroscopic methods, 
have been used to investigate labile metal pools in mitochondria. The most popular 
strategy entails custom-designed chelators that are localized to mitochondria and bind 
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specifically (or at least preferentially) to a particular metal. These chelator-based sensors, 
or probes, must be hydrophilic enough to be soluble in aqueous regions of the cell, yet 
lipophilic enough to traverse membranes. Satisfying these criteria is a formidable 
endeavor that requires considerable synthetic abilities. Fluorescence associated with these 
molecular probes either increases, decreases, or shifts upon metal coordination. A key 
property of most fluorescent probes is that the signal response is ratiometric and affords 
an estimation of the labile metal concentration. The major advantage of this strategy is 
that it is relatively non-disruptive with respect to the integrity of the cell itself, which is 
particularly useful for monitoring dynamic changes to LMPs in live, intact biological 
samples (e.g., tissues, cells, or isolated organelles). Also, this method provides valuable 
in vivo snapshots of LMPs with high spatial and temporal resolution. Custom-engineered 
chelator sensors are highly tunable and designed to probe a dynamic range of 
concentrations. As sensors become more specific and sophisticated, they will become 
more helpful in understanding the cellular function of LMPs. 
The alternative strategy for investigating LMPs is to fractionate and identify 
individual metal complexes via liquid chromatography (LC). LC is an effective 
bioanalytical technique that offers several different mechanisms of chemical separation. 
Different types of LC can be combined to yield separations with higher degrees of purity. 
The application of inductively coupled plasma mass spectrometry (ICP-MS) allows for 
sensitive detection of various transition metals in complex sample matrices over a dynamic 
concentration range. This approach is the most direct method to characterize metal 
complexes and is limited to those that do not decompose during chromatographic workup. 
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Evidence of decomposition would include chromatography peaks corresponding to 
aqueous (“free”) metal ions or adherence to the column. 
Both approaches have contributed valuable insights to the current understanding 
of labile metal pools in biological systems, yet each has shortcomings. A significant 
limitation of the chelator-based method is that the ligands associated with an endogenous 
metal complex are inevitably displaced when the probe coordinates the metal. Thus, 
chemical characterization of such complexes has not been possible and does not seem 
possible moving forward. Moreover, a given chelator will almost certainly interact with 
numerous labile metal species, perhaps including sites that are typically considered 
nonlabile, e.g., metalloprotein active sites. Different chelators (or even the same chelator 
reacting under different conditions) undoubtedly detect different LMPs. Some of these 
problems have been demonstrated recently with Zn sensors,47 and other fundamental 
questions remain unanswered. For example, do probes targeted to mitochondria interact 
with labile metal centers in the cytosol en route to their target? Might the resulting metal-
bound probes enter mitochondria and thus be counted (erroneously) as evidence of a 
mitochondrial pool? Is the concentration of the chelator that ultimately localizes to the 
mitochondria sufficient such that the endogenous concentration of labile metal (rather than 
of the chelator itself) dictates the extent of reaction and thus the observed pool size? Many 
of these questions have been raised,45,47,48 but they must be settled experimentally before 
confidence can be placed in the results obtained by this approach. 
A major drawback of the chromatography-based strategy is that the structural 
integrity of cells and organelles are compromised during the isolation of metal complexes. 
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As a result, cellular contents are mixed together, which can promote side reactions 
involving these labile metals, giving rise to artifacts. Thus, LC peaks observed in 
chromatograms might be artifacts of the isolation procedure. Past LC studies of metal 
complexes have been plagued with a lack of demonstrated reproducibility in 
chromatograms, which is a serious concern. Unfortunately, metal complexes are difficult 
to isolate because of their lability and low concentrations. There is also a lack of 
commercially available technologies (e.g., chromatography columns) designed and 
optimized to help isolate these complexes from biological extracts. Another problem is 
that isolated mitochondria may not be pure, and contaminating species from other cellular 
compartments can confuse analyses. Typically, the purity of these organelles is assessed 
by microscopy and Western blots. Ascertaining the cellular function of a metal complex 
that has been isolated from mitochondria is difficult. However, additional information can 
be obtained by fractionating mitochondria into subcomponents.49 
Overall, the chelator-based strategy may be better suited for addressing functional 
aspects of LMPs, whereas the chromatography-based approach may be better suited for 
cataloging and chemically characterizing individual metal complexes that compose LMPs. 
Ultimately, complementary insights from both approaches will be needed to adequately 
characterize LMPs and to elucidate their physiological roles. 
 
Implications in Disease Pathogenesis 
Disruption of metal ion homeostasis in the mitochondria has been implicated in 
the pathogenesis of several human diseases and disorders. In particular, perturbations in 
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the concentrations of LMPs may be linked with pathological consequences. At the cellular 
level, excessive concentrations of labile redox-active metals such as iron, copper, and 
cobalt can induce oxidative stress in living systems by generating ROS (reactive oxygen 
species) like hydrogen peroxide and superoxide radical. ROS are toxic to the cell because 
of their propensity to destroy critical biomolecules including proteins,50 DNA,51 and 
lipids.52 Metal-induced oxidative stress has been associated with triggering the onset of 
ageing and cancer. The deleterious potential of metals can be nullified by stimulating their 
incorporation into the active sites of recipient apoproteins. Clearly, adequate levels of 
bioavailable metal pools are required for the efficient metalation of mitochondrial proteins 
and enzymes. With this in mind, diminished concentrations of LMPs can lead to 
detrimental mismetalation of protein targets, leading to their inactivation. These damaging 
effects caused by misregulation of homeostatic concentrations of LMPs are suspected 
factors in disease progression. 
Elevated levels of labile zinc, copper, and iron pools are suspected to play a 
significant role in causing neurodegenerative disorders such as Alzheimer’s disease (AD) 
and Parkinson’s disease (PD).53-56 Increased levels of zinc may induce the aggregation of 
beta amyloid plaques in the brain, which happens to be one of the most prominent 
characteristics associated with AD.57 Misregulation of copper and iron pools is thought to 
contribute in the pathogenesis of AD and PD. Excess levels of these labile metals are 
connected with the formation of metal-bound protein aggregates that facilitate the 
accumulation of beta amyloid plaques in AD58 and Lewy bodies in PD.59,60 Aside from 
neurodegenerative conditions, disruption of iron homeostasis is considered to participate 
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in cancer formation and pathogenesis of cardiovascular diseases via ROS-mediated 
toxicity.61 For instance, the labile iron pool may play a role in the development of 
atherosclerosis—one of the leading risk factors for coronary heart disease—by catalyzing 
the production of ROS, which can oxidize low density lipoproteins forming the plaque 
deposits within arterial walls.62 
Labile metal pools have long been suspected to play key roles in the etiology and 
progression of various diseases. Their link to disease has been predominantly based on the 
general mechanism that LMPs, when present in excess levels, are able to generate ROS 
known to induce extensive cellular damage. However, after decades of research on these 
pools, no studies have successfully established a direct causative link to disease 
pathogenesis. Elucidating the roles and molecular complexes associated with LMPs will 
therefore be instrumental to understanding how they participate in pathology. Such 
investigations into the chemical nature of bioavailable metal pools offer significant 
potential for clinical therapeutic applications. 
 
Low-Molecular-Mass Metal Complexes in Mitochondria 
Mitochondrial labile metal pools are thought to be comprised of low-molecular-
mass (LMM) metal complexes—defined here as having masses of less than 10 kDa—that 
are, for the most part, nonproteinaceous. Simple monodentate ligands tend to exchange 
rapidly when coordinated to first-row d-block metal ions. For example, aqueous MnII, FeII, 
CoII, CuII, and ZnII complexes have water-exchange rates ranging from 106 to 109 sec-1.63 
Unfortunately, this lability makes isolating and characterizing such complexes difficult. 
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Ligand-exchange kinetics are slowed dramatically when metals coordinate to large 
polydentate ligands (e.g., protein metal binding sites). As a result, most metals bound in 
proteins are relatively inert except for the open coordination sites to which substrates bind. 
Non-protein-bound LMM metal complexes tend to be more labile, though there are 
exceptions to this tendency. For instance, metals that are bound to metallochaperone 
carrier proteins must be sufficiently labile to facilitate delivery to downstream intracellular 
targets. Also, some metalloenzymes contain labile metal centers.64 Other exceptions are 
siderophores, LMM organic chelating agents secreted by certain microorganisms to 
sequester trace amounts of FeIII from the environment.65 These LMM iron complexes are 
generally inert, except at low pH.  
In this review, we detail recent discoveries and highlight current controversies 
surrounding labile LMM metal complexes in mitochondrial biochemistry. 
 
Copper 
Initial studies by Winge, Cobine, and co-workers concluded that 70 – 85% of 
mitochondrial Cu is associated with a LMM complex found in the matrix called CuL.44,66 
An elaborate isolation procedure is employed to purify CuL. Cellular extracts are treated 
with 100% methanol. The resulting extracts are dried and resuspended in aqueous 
solutions before being loaded onto an anion-exchange column. Fractions containing the 
CuL apo ligand are dried and resuspended in water prior to injection onto a C18 reverse-
phase column. Ligand-containing fractions elute in the middle of a methanol gradient and 
are subsequently screened for fluorescence.67 CuI is added to fractions containing the 
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purified apo ligand, resulting in the formation of CuL as indicated by fluorescence 
quenching. The material obtained from this rather involved procedure, defined as CuL, is 
soluble, anionic, and stable to boiling and migrates on size-exclusion columns like a 
globular protein with a mass of 13,000 Da.44 However, CuL exhibits no absorption at 280 
nm and is unaffected by proteinase K treatment, suggesting that it is nonproteinaceous. In 
terms of biological significance, Winge and Cobine view the CuL pool as a reservoir or 
“dynamic rheostat” that is used to buffer intracellular copper levels. They hypothesize that 
the Cu in CuL is ligated by small metabolites such as organic acids or nucleotides. They 
suggest that the CuL ligand prevents mitochondrial Cu from damaging ISCs that are 
generated in the matrix. 
These researchers hypothesize that CuL is originally produced in the cytosol and 
imported into the matrix by Pic267 and Mrs3,68 both of which are MCF members. They 
conclude that Pic2 mediates the transport of Cu into the matrix, which is supported by the 
observation that Dpic2 cells exhibit a growth phenotype on synthetic Cu-deficient 
nonfermentable medium (whereas growth on Cu-sufficient media shows no phenotype). 
Moreover, increasing the amount of silver ions in the growth medium, which directly 
compete with Cu ions, exacerbates the growth defect. The rate of Cu uptake in Dpic2 
mitochondria is nearly half that for wild-type (WT) mitochondria. Consistent with this, 
the concentration of Cu within mitochondria from Dpic2 cells is only ~70% relative to that 
in WT mitochondria. Together, these results infer the existence of an alternative 
mitochondrial Cu transport protein, presumably Mrs3.68 
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Other aspects of mitochondrial copper metabolism occur in the IMS.69 During 
assembly of cytochrome c oxidase, Cu is transported into the IMS where it is incorporated 
into the CuB and CuA sites of the enzyme using a variety of required ancillary proteins. 
Metalation of Cu/Zn Sod1 also occurs within the IMS and is mediated by the Cu chaperone 
Ccs1.4 The form of Cu that enters the IMS and the compartment from which it enters 
remain unresolved. Winge and Cobine conclude that CuL is shuttled into the IMS from 
the matrix by an unidentified IM carrier.66,68 However, with a mass of 13,000 Da, CuL is 
too large to diffuse through a carrier protein channel.70 Another possibility is that Cu from 
the cytosol is directed into the IMS by Cox17, a soluble 8 kDa protein containing a CuI 
center coordinated by three conserved cysteines.71-75 Indeed, this protein is found in both 
the IMS and cytosol.73 However, Cox17 is translocated into the IMS by the Mia40 
oxidative folding pathway, meaning that it arrives in the IMS as an unfolded 
apoprotein.76,77 Moreover, Maxfield et al. demonstrated that tethering Cox17 to the IM 
affords normal cytochrome c oxidase activity,78 indicating that it does not import Cu from 
the cytosol. The Cu trafficking pathway downstream of Cox17 is better characterized. 
Cox17 supplies Cu to Cox11 (34 kDa) and Sco1 (33 kDa) through specific protein-protein 
interactions. Other small soluble Cu binding IMS proteins involved in the metalation of 
cytochrome c oxidase include Cox19 (11 kDa) and Coa6 (12 kDa).79,80 
Labile Cu pools in mitochondria have been detected by chelator-based sensors. 
Yang et al.81 used a membrane-permeable copper-selective fluorescent probe along with 
X-ray fluorescence microscopy to detect and characterize a labile pool of low-coordinate 
CuI with sulfur-based ligands in mitochondria of fibroblasts that had been pretreated with 
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a high concentration of CuCl2. Cu-based signals were nearly undetectable in samples that 
were not treated in this manner, which raises concern that newly imported copper arising 
from the Cu treatment was detected, rather than endogenous Cu in the organelle. 
Nevertheless, the authors concluded that their results “strongly support” the presence of 
an endogenous labile Cu pool within the mitochondrial matrix. In this case, substantial 
amounts of the Cu matrix pool should have also been found in mitochondria of cells grown 
on medium that was not spiked with Cu, a condition for which Yang et al. detected little 
Cu intensity.81 
Better evidence of endogenous labile Cu in mitochondria is provided by Dodani et 
al.,82 who similarly employed a mitochondrially-targeted Cu sensor to detect labile copper 
pools within the organelle. Fluorescence increased 34% in live, intact cells that had been 
incubated in high concentrations of CuCl2. Conversely, emission decreased 36% after a 
strong Cu chelator had been added, which presumably entered the mitochondria and 
coordinated endogenous Cu in the organelle. Giuffrida et al. developed a water-soluble 
highly selective fluorescent CuI probe that is specific for mitochondria.83 No significant 
effects on cell viability were observed after neuroblastoma cells had been treated with 
large doses of this chelator. This confirms that the sensor does not damage the cell, but it 
also raises doubts that it chelates a form of Cu that is physiologically relevant. 
 
Zinc 
Winge, Eide, and co-workers have also detected and isolated a cationic LMM Zn 
pool in mitochondrial extracts.84 The pool is stable to boiling and proteinase K digestion, 
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suggesting that it is not proteinaceous. Under Zn-sufficient growth conditions, 
approximately half of mitochondrial Zn is soluble, and a significant portion of this 
comprises the Zn pool. When cells are grown on high-Zn medium, the size of the pool 
increases significantly. Reducing the size of the pool (by genetically inserting a Zn-
requiring alcohol dehydrogenase apoprotein into the matrix, which then incorporates Zn 
from the pool during metalation) causes cells to have difficulty respiring. This suggests 
that the Zn pool is required for respiration. 
Labile Zn pools in mitochondria have also been identified using fluorescent 
probes. Tomat et al.85 synthesized a Zn-sensitive chelator that was targeted to the 
mitochondria of HeLa cells. In their study, they observed a dramatic increase in 
fluorescence intensity after cells were treated with 10 – 50 µM ZnCl2. Sensi et al. detected 
a pool of labile Zn ions in mitochondria from mammalian neuronal cells.43 This pool was 
in dynamic exchange with a labile cytosolic Zn pool, and its size increased in cells grown 
on medium supplemented with Zn.43,86 High levels of cytosolic Zn induce loss of 
mitochondrial membrane potential (DYm), perhaps by opening IM channels or pores. 
Malaiyandi et al. used sensors to monitor the uptake of exogenously added Zn in the matrix 
of mitochondria isolated from rat brains.87 Zn2+ was imported via a Ca2+ uniporter in a 
process that required DYm. Zn2+ can also be imported into mitochondria via ZnT-type IM 
transporters, e.g., ZnT2 in mammalian systems.9,87-91 
In the study by Malaiyandi et al., targeted mitochondria exhibited a weak 
fluorescent response, inferring low endogenous levels of labile Zn.100 87 Treatment with 
Zn caused a sudden increase in emission, which indicated an increase in the size of the 
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labile Zn pool. Emission quickly returned to baseline levels, suggesting that mitochondria 
can rapidly export excess Zn, perhaps via the ZIP8 transporter in mammals.91 Zn enters 
mitochondria only when supraphysiological amounts are added. DYm decreases when 
mitochondria are treated with high levels of Zn, presumably because Zn binds to the 
exterior of the organelle.92 The effect of Zn on the mitochondrial permeability transition 
pore differs from that of calcium.93,94 
High concentrations of mitochondrial Zn, obtained by either incubating isolated 
mitochondria in solutions spiked with excess Zn or using genetic strains that disrupt Fe 
metabolism, can have deleterious effects. FeIII nanoparticles accumulate in the 
mitochondria of yeast cells lacking the frataxin homologue (Yfh1), which also contain 
deficient amounts of ISCs and hemes.95 What is less commonly realized is that Zn-
protoporphyrin IX accumulates in mitochondria from this same strain.96,97 This probably 
occurs because mitochondrial FeII, which in WT cells is used by ferrochelatase to metalate 
protoporphyrin IX, has been converted into oxidized nanoparticles that cannot be installed. 
Under these conditions, ZnII can substitute for FeII in the ferrochelatase reaction. The 
mismetalation of Zn does not arise because of excess ZnII; in fact, Dyfh1 cells import only 
a fraction of the Zn imported by WT cells.98 Rather, misincorporation arises because of 
the scarcity of FeII.88 Accordingly, Zn-protoporphyrin is also observed in Fe-deficient 
cells.88,96,97,99 Curiously, excess ZnSO4 in the medium (a) prevents the accumulation of Fe 
in mitochondria of Dyfh1 cells, (b) increases the growth rate of this strain, and (c) mitigates 
ROS damage. Surprisingly, these responses are not caused by an increase in ISC or heme 
synthesis, which makes them difficult to explain. Accumulation of Fe in ISC mutants is 
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thought to arise from insufficient ISC (and/or heme) biosynthesis. Lower-than-normal 
ISC/heme biosynthetic activities are thought to diminish the rate of export of X-S, the 
unknown sulfur-containing product that is a cytosolic signaling molecule for these 
mitochondrial processes. X-S has been posited to regulate cellular Fe import via a 
signaling pathway involving glutaredoxins and the transcription factors Aft1/2.100 The fact 
that Zn added to the exterior of mitochondria suppresses this regulatory mechanism 
implies that it can functionally substitute for X-S, but how this might work is not obvious. 
Excess Zn inhibits the TCA cycle, decreases the rate of respiration, inhibits the respiratory 
electron transport chain,101 and stimulates ROS production.43,86 Gazaryan et al. found that 
picomolar concentrations of aqueous Zn inhibit a-ketoglutarate dependent mitochondrial 
respiration by inhibiting lipoamide dehydrogenase.115 102 Perhaps these inhibitory effects 
indirectly regulate Fe import. 
Also involved in mitochondrial Zn metabolism is Mzm1, a soluble 14 kDa protein 
found in the matrix that helps maintain the labile Zn pool in the matrix and stabilize 
respiratory complex III.84,103 Dmzm1 mutant cells grow poorly on nonfermentable carbon 
sources when Zn is limited in the growth medium. Mitochondria isolated from these cells 
contain decreased amounts of Zn, but not Fe, Cu, Mn, or Mg. They also exhibit decreased 
respiratory complex III activity. Zn is also critical for autophagy.104 Zn deficiency induces 
apoptosis by activating the mitochondrial cell death pathway.88 
The concentration of labile Zn in mitochondria is reported to be extraordinarily 
low.37 McCranor et al.105 used a FRET-based biosensor derived from carbonic anhydrase 
II variants that were targeted to the matrix of mitochondria of mammalian cells. The 
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biosensor was exquisitely sensitive to and specific for labile Zn. They reported a labile Zn 
concentration in the matrix of ~0.15 pM! When cells were deprived of glucose and O2 for 
3 h and then reperfused in O2, there was an initial surge in labile mitochondrial Zn (as 
cytosolic levels declined); mitochondrial Zn levels returned to normal after reperfusion 
for 2 h. In another study, Park et al.106 used a genetically encoded protein-based Zn sensor 
that was targeted to mitochondria to measure the labile Zn concentration in the organelle. 
Zn binding induced a conformational change that was monitored by FRET. They reported 
a concentration of 0.14 pM for labile Zn, far lower than the concentration of the labile Zn 
pool in the cytosol. 
 
Manganese 
MnSod2 is directed to the mitochondrial matrix by an N-terminal targeting 
sequence.107 Once inside the matrix and once the targeting sequence has been clipped, the 
resulting apoprotein folds with help from Hsp60/Hsp10.108,109 In the absence of its 
targeting sequence, apo-Sod2 is neither folded nor metalated, suggesting that metalation 
occurs during folding of Sod2. 
How cytosolic Mn is transported into the matrix for metalation is unknown. As a 
member of the MCF, Mtm1 was initially considered to be a Mn transporter and was thus 
named the manganese trafficking factor for mitochondrial Sod2 because cells lacking it 
exhibit low Sod2 activity.98,110 Contrary to the behavior expected for this role, the 
concentration of Mn in the matrix was higher in Dmtm1 mutants than in WT cells. 
Attention turned to iron when the absence of Mtm1 was found to cause Fe to accumulate 
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in the matrix. Iron accumulation along with the propensity of bacterial MnSods (e.g., in 
Escherichia coli MnSod) to misincorporate Fe seemed to explain the diminished MnSod2-
based activity in the Dmtm1 yeast strain. The results of initial chromatography studies of 
Sod2 supported the misincorporation hypothesis.111 Namely, when Dmtm1 soluble 
extracts were chromatographed, most of the eluted Fe comigrated with Sod2. In 
chromatographs of WT extracts, most of the eluted Mn comigrated with Sod2. 
An X-ray absorption spectroscopy study112 subsequently demonstrated that the 
vast majority of Fe that accumulated in Dmtm1 mitochondria had not misincorporated into 
apo-Sod2. A corresponding Mössbauer study revealed that mitochondrial Fe accumulated 
as FeIII oxyhydroxide nanoparticles,113 similar to the Fe accumulation phenotypes 
observed in ISC mutants such as Yah1-depleted or Atm1-depleted mitochondria.114,115 
Moreover, little of the Fe that accumulated in Dmtm1 mitochondria was in a form  (i.e., 
FeII) that could be misincorporated. Another surprise was that Fe did not accumulate in 
Dmtm1 cells grown anaerobically, but they did have low Sod2 activity. This indicated that 
the two phenomena, Fe accumulation and low Sod2 activity, were independent.113 
Previously, Park et al. used an LC-ICP-MS system in an effort to detect 
misincorporated Fe Sod2. In chromatograms of extracts from Dmtm1 versus WT cells, 
they observed reduced protein and activity levels of MnSod2 but no increase in putative 
FeSod2 features.113 Quantitative accounting of Mn concentrations and Sod2 protein levels 
revealed that the majority of Sod2 protein was missing in soluble fractions, suggesting 
that apo-Sod2 proteins in mitochondria lacking Mtm1 are less stable toward folding and 
metalation with Mn. 
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Supporting this new hypothesis was a LMM Mn species whose concentration was 
increased in Dmtm1 mitochondrial extracts, as would be expected if apo-Sod2 was 
unfolded and unstable and could not be metalated. The LMM Mn species (called Mn2-3) 
was estimated to have a molecular mass of 2000 – 3000 Da. Mn2-3 was also present in WT 
cells, but at a concentration of just 1 µM (12% of mitochondrial Mn). In Dmtm1 
mitochondria, the corresponding concentration was 22 µM (80% of mitochondrial Mn). 
In WT mitochondria from cells supplemented with excess MnCl2, the concentration of 
Mn2-3 increased to 23 µM (there was no change in MnSod2 levels). Because MnSod2 was 
the only Mn-containing peak in chromatograms and Mn2-3 was the only LMM Mn species 
observed, Park et al. hypothesized that Mn2-3 was imported into the matrix through an 
unknown IM transporter and that this complex was used to metalate apo-Sod2. They 
further hypothesized that Mtm1 imports a species that is required for the maturation, 
activity, or stability of apo-Sod2, and that there is a competition of maturation and 
metalation versus misfolding and degradation. A recent study by Whittaker et al.116 reveals 
that Mtm1 binds pyridoxal 5’-phosphate (PLP) with micromolar affinity, prompting them 
to conclude that Mtm1 transports PLP into the matrix. Consistent with this, PLP-
dependent proteins in Dmtm1 mitochondria lack this coenzyme. Heme and ISC 
biosynthetic pathways depend on PLP, explaining the connection between Mtm1 and 
mitochondrial Fe metabolism, but how a deficiency in PLP translates into a decline in 
Sod2 activity in Dmtm1 cells remains a mystery; the case would be settled if mitochondria 
were found to contain a PLP-dependent protein that mediates the folding, maturation, 
and/or metalation of apo-Sod2. 
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Cobalt 
Cobalt enters mammalian cells in the form of cobalamin, which is then transported 
to various intracellular locations. The cobalamin delivered to mammalian mitochondria is 
used to metalate apo-MUT, the only known Co-containing enzyme in this organelle.117 
However, the mitochondrial cobalamin transporter on the IM remains obscure. Once 
co(II)balamin reaches the matrix, it binds ATP:cob(I)alamin adenosyltransferase 
(MMAB), is reduced to the Co(I)balamin state, and then accepts a 5-deoxyadenosyl group 
from ATP.118 MMAB then incorporates the resulting adenosylcob(III)alamin into apo-
MUT.119 MMAA, a GTPase “gatekeeping G-protein chaperone,” binds MMAB and apo-
MUT to regulate the installation of adenosylcob(III)alamin.120 
 
Molybdenum 
The mechanism by which sulfite oxidase (SO) is assembled in the IMS of 
mammalian mitochondria and then metalated with the molybdopterin cofactor (Moco) and 
heme centers has been investigated.121 Mitochondrial localization is dictated by an N-
terminal sequence that targets this protein to the IMS via the TOM complex. Upon being 
imported into the IMS, the targeting sequence is cleaved by mitochondrial IM peptidase, 
followed by the incorporation of Moco into the apo-SO protein, which initiates folding 
and traps the enzyme within the IMS. SO also contains heme b, but this cofactor does not 
play a major role in folding or trapping. How Moco is shuttled across the OM is unclear; 
it might pass through a transporter or just diffuse through VDAC pores. The assembly of 
molybdopterin requires the coordinated action of multiple enzymes in the cytosol,122 such 
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that Moco is likely installed as a complete unit into mitochondrial Mo enzymes. Moco is 
unstable in protein-free solutions,123 suggesting that its translocation into the IMS 
coincides with its insertion into apo-SO.121 A pool of free, non-protein-bound Moco was 
detected in mitochondria, which might be an intermediate in the installation process. 
Two Mo-containing enzymes, mARC1 and mARC2, are associated with the OM 
of mammalian mitochondria where they function with cytochrome b5, NADH, and 
NADH-cytochrome b5 reductase to reduce various N-hydroxylated compounds and 
convert nitrite ion into nitric oxide.124-126 Both mARC1/2 proteins are small (6 – 22 kDa) 
and possess broad substrate specificity. Developmental expression profiles reveal distinct 
differences between the two isoforms, suggesting that their expression is controlled by 
independent regulatory mechanisms. mARC2 is only expressed in adult livers where it is 
involved in lipogenesis and is regulated by nutritional status. This protein may have dual 
localization in mitochondria and peroxisomes. mARC1 is expressed in both adult and fetal 
tissues.127 It has characteristics of a typical OM protein in which the C-terminal catalytic 
domain is exposed to cytosol and the N-terminal domain points towards the IMS.128 Moco 
in the SO family of molybdenum hydroxylases contains a Mo center coordinated by a 
cysteine thiolate and two oxo groups. Moco in mARC1/2 is of the SO type,129 suggesting 
that the Moco unit, which is installed in both SO and mARC1/2, originates from a common 
source. 
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Iron 
The most prominent mitochondrial transporters of transition metals are mitoferrins 
1 and 2. Counterparts of mitoferrin 1/2, called Mrs3 and Mrs4, are present in yeast. These 
homologous proteins are high-affinity iron transporters situated in the IM.130-133 They are 
members of the mitochondrial carrier family (MCF), which includes 53 proteins in 
humans and 35 proteins in yeast.134 The physiological differences between mitoferrin 1 
and 2 (or Mrs3/4) pairs have yet to be fully established. Mitoferrin 1 is an essential iron 
importer for developing erythrocytes, whereas mitoferrin 2 may be required for heme and 
ISC assembly in nonerythroid cells.130 The iron transported through these high-affinity 
importers is ultimately utilized in the biosynthesis of ISC and heme cofactors.99,135 Indeed, 
the majority of Fe that accumulates in mitochondria of ISC mutants (e.g., frataxin-
deficient cells) passes through these carrier proteins. 
Rim2, another MCF protein, translocates Fe ions and pyrimidine nucleotides.136,137 
In the absence of Mrs3/4, Rim2 has been shown to mediate the import of Fe into the 
matrix. Interestingly, the extent of ISC biogenesis is diminished in yeast cells that lack 
Mrs3/4 and Rim2 but not in cells lacking only Rim2. This implies that Rim2 is a backup 
low-affinity Fe importer. The non-lethality of the Mrs3/4 and Rim2 triple deletion strain 
implies an additional route of Fe import into mitochondria. 
The Fe complexes that are recognized by these mitochondrial import proteins have 
not been identified. In general, MCF members transport a variety of chemically diverse 
substrates across the IM, such as nucleotides, amino acids, keto/carboxylic acids, 
phosphate ions, and cofactors. Although the structures of many MCF members, including 
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the mitoferrins, have not been determined, their sequences are similar enough that an 
approximate structure can be estimated. Mitochondrial carrier proteins have basket-
shaped structures. The bottoms of these structures face the matrix side and are structurally 
stabilized by salt bridge networks. They have a common substrate binding site located at 
the midpoint of the IM.138 Mitoferrins possess three conserved His ligands that are 
spatially arranged like steps of a spiral staircase to shuttle FeII ions across the membrane,139 
along with three conserved Asp/Glu residues that may participate in metal transport. 
Mitoferrins do not belong to any established class of MCF proteins, so their substrates are 
unlikely to be similar to those listed above. Nevertheless, their substrates must be small 
enough to fit through the narrow channels in these proteins. This excludes large 
metallochaperones from consideration as substrates and suggests that LMM metal 
complexes may serve such roles.  
An early study by Tangerås et al.140 identified a labile Fe pool in mitochondria 
isolated from rat livers. In their study, extracts were treated with bathophenanthroline 
sulfonate (BPS), a chelating agent that turns red when coordinated to FeII, thereby 
permitting quantification of the labile FeII concentration in their samples. Their findings 
suggest that ~25% of mitochondrial Fe is labile and primarily located in the matrix. In a 
later study, Petrat et al.141,142 used membrane-permeable chelators to detect and quantify a 
labile Fe pool within mitochondria of intact whole cells. They incubated cells with 
fluorescent probes that penetrated into mitochondria and quenched in response to binding 
Fe. Subsequent treatment with a more powerful chelator removed all of the Fe bound to 
the sensor, concomitantly restoring the fluorescent signal. The difference in emission was 
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then quantified, affording labile Fe concentrations of 5 – 17 µM in rat mitochondria.42 
Mitochondria contain ~700 µM Fe,62 so the labile Fe fraction, as quantified, corresponds 
to 1 – 2% of mitochondrial iron, far less than what was determined by Tangerås and co-
workers. Petrat et al. postulated that the higher concentration reported in the earlier study 
was artifactual.141,142 
More recently, we examined mitochondria isolated from fermenting and respiring 
yeast cells using Mössbauer spectroscopy,143 which can distinguish various groups of Fe-
containing species, including hemes, ISCs, and non-heme Fe. They discovered that ~20% 
of the iron in fermenting mitochondria (~150 µM) is present as non-heme high-spin 
(NHHS) FeII.144 Membrane-impermeable chelators were unable to access this pool of iron 
unless mitochondria were disrupted by sonication or treated with detergent. By contrast, 
membrane-permeable Phen selectively chelated the NHHS FeII ions without perturbing 
the other Fe-containing species in the organelle. In independent studies, Lutz et al.145 and 
Pandey et al.146 developed assays for monitoring ISC biogenesis in intact mitochondria. 
These investigators found that treating isolated mitochondria with Phen inhibits ISC 
activity. They concluded that mitochondria contain a pool of labile Fe that is used as 
feedstock for ISC assembly. When considered with our Mössbauer results showing that 
NHHS FeII is selectively chelated by phen, it becomes evident that this pool of NHHS FeII 
is used as feedstock for ISC assembly and that it is probably transported through mitoferrin 
carriers. 
The same pool might also be feedstock for heme biosynthesis, but further studies 
are required to establish this. Lange et al. concluded that Fe in the matrix is not used for 
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insertion into porphyrin and that Fe is supplied to ferrochelatase directly from the IM.147 
However, the subsequent structure of ferrochelatase revealed that the FeII binding site is 
exposed to the matrix, implying that heme Fe is contributed by a pool in this 
subcompartment.148 Dancis and co-workers performed experiments demonstrating that 
most FeII ions used in heme biosynthesis enter the matrix through the IM mitoferrins, 
Mrs3/4.99 
The coordination chemistry of iron and glutathione (GSH) may be relevant to this 
issue. GSH represents about ~90% of cellular LMM sulfur-containing species,149 with 10-
15% of that located in mitochondria.150 The concentration of GSH in mitochondria is very 
high (10 – 14 mM).151,152 Hider and Kong argue that an FeII(GSH) adduct is the major 
LMM Fe complex in the cytosol based on a high stability constant for the complex and 
the abundance of GSH within the cytosol.153 A similar argument could be made for LMM 
FeII(GSH) adducts in the mitochondrial matrix. Citrate, another metabolite present in the 
matrix at high concentrations, should also be considered as a potential ligand for LMM 
metal complexes.152,154 
Another aspect of iron:GSH metabolism occurring in yeast mitochondria involves 
the IM protein Atm1 (ABCB7 in humans). Atm1 exports a poorly defined LMM sulfur-
containing species called X-S, which is used as feedstock for ISC assembly in the cytosol 
and as a signaling molecule that regulates the import of iron into the cell and mitochondria. 
The Atm1 structure has either GSH, GSSG (glutathione disulfide), or GSSH (glutathione 
peroxide) bound, suggesting that it catalyzes the export of these or similar molecules (e.g., 
the trisulfide GSSSG) into the cytosol.155,156 GSH also coordinates Fe2S2 clusters, and the 
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[Fe2S2(GS)4]2- complex has been proposed to be present in mitochondria and exported by 
Atm1.157 
 
Objectives 
Research in the Lindahl Lab is aimed at understanding fundamentals of iron 
metabolism in cells. This involves studying important iron-related cellular processes such 
as trafficking, homeostasis, and regulation. One of the biggest mysteries in the field of 
iron metabolism, standing at the nexus of these three research areas, is the mitochondrial 
labile iron pool (LIP). The presence of this compartmentalized endogenous pool of iron 
has been predominantly established with fluorescent chelator probes. Furthermore, 
Holmes-Hampton et al. identified a pool of non-heme high-spin (NHHS) FeII localized 
within yeast mitochondria via Mössbauer spectroscopy.144 Aside from this, however, the 
chemical nature of the LIP remains largely uncharacterized. The primary objective of this 
dissertation was to implement an integrative biophysical and bioanalytical approach to 
investigate the mitochondrial LIP. 
The iron pool is widely considered to consist of labile iron complexes weakly 
coordinated to nonproteinaceous LMM ligands. This is rationalized based on size 
restrictions imposed by the channels of essential transport proteins situated in the OM and 
IM. The objective in chapter III of this dissertation was to establish the presence of LMM 
iron complexes (i.e. < 10 kDa) in mitochondria. Additionally, we evaluated the presence 
of such iron species in mammalian mitochondria. LMM complexes containing other 
biologically relevant elements such as manganese, zinc, copper, cobalt, molybdenum, 
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phosphorus, and sulfur were also studied. To accomplish this goal, we utilized a 
bioanalytical approach involving size-exclusion chromatography (SEC) for separation and 
isolation of LMM complexes in mitochondria in combination with ICP-MS for multi-
element detection and analysis. Moreover, this online LC-ICP-MS system was 
encapsulated in a refrigerated anaerobic glove box to reduce ligand-exchange and prevent 
oxidation of LMM iron/metal complexes. McCormick et al. used this system to detect and 
catalog distinct LMM metal complexes in the mouse brain and to determine their 
approximate molecular masses and concentrations.158 
In Saccharomyces cerevisiae, two homologous proteins belonging to the 
mitochondrial carrier family (MCF) termed Mrs3 and Mrs4 (Mrs3/4) mediate iron uptake 
across the IM.131,133 These proteins are essential for importing cytosolic iron into the 
matrix under iron-limiting conditions.132 In addition, the iron transported by Mrs3/4 is 
ultimately utilized in the biosynthesis of ISCs and heme cofactors.99 The identity of the 
endogenous iron complex transported by Mrs3/4 has not been identified. We hypothesized 
that Mrs3/4 import a LMM iron complex that composes a large portion of the 
mitochondrial labile iron pool. This hypothesis was investigated in further detail in chapter 
IV of this dissertation using a Mrs3/4 double-deletion (∆∆) mutant yeast strain. We 
employed biophysical techniques including Mössbauer, EPR, and UV-Vis spectroscopies 
to probe the iron content, distribution, and speciation in respiring Mrs3/4-deficient whole 
cells and isolated mitochondria. Finally, ∆∆ mitochondria were analyzed for LMM iron 
complexes with the aforementioned LC-ICP-MS system. 
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CHAPTER II 
MATERIALS AND METHODS* 
 
Biophysical Methods Used 
The application of molecular genetics and biochemistry has promoted a greater 
understanding of iron metabolism in eukaryotic cells. In particular, such methodology has 
proven valuable for identifying key players involved in iron uptake, trafficking, storage, 
and homeostasis. Conventionally, this has been accomplished by characterizing 
phenotypes resulting from genetic manipulation (e.g., deletion or mutation) of a protein or 
enzyme of interest. Biophysical techniques have also been employed for characterization 
but mainly in the context of isolated protein studies. 
In Chapter IV of this dissertation, several biophysical methods were used to 
investigate the mitochondrial labile iron pool from a systems-level perspective. The 
principal technique used for biophysical analysis was Mössbauer spectroscopy, while 
electron paramagnetic resonance (EPR) and ultraviolet-visible (UV-Vis) spectroscopy 
were utilized as auxiliary tools. Inductively coupled plasma mass spectrometry (ICP-MS) 
was employed to measure absolute metal concentrations. Clues obtained from each of 
these methods were integrated to form a “big picture” of the distribution and speciation of 
iron in whole cells and isolated mitochondria. 
                                                
* Adapted with permission from Sean P. McCormick, Michael J. Moore, and Paul A. 
Lindahl (2015) Detection of Labile Low-Molecular-Mass Transition Metal Complexes 
in Mitochondria, Biochemistry 54, 3442–3453. Copyright 2015 American Chemical 
Society. 
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Mössbauer Spectroscopy 
Mössbauer (MB) spectroscopy is one of the most powerful methods for 
investigating intracellular iron trafficking and metabolism. The principles behind MB 
spectroscopy, which is more specifically described as recoilless nuclear gamma-ray 
resonance, were discovered in 1958 by the physicist, Rudolf Mössbauer.159 In this 
technique, nuclei in samples absorb gammy ray photons emitted from a radioactive source 
and undergo transitions to an excited nuclear spin state. The energy of emitted gamma ray 
photons is altered via the Doppler Effect by moving the source towards and away from 
the fixed sample. Typical MB spectra are plotted with the absorption intensity (or percent 
effect) on the y-axis and the velocity of the moving source (in units of mm/s) on the x-
axis. There are only a few elements that are MB active, which requires using specific 
radioactive sources. 
With respect to iron, MB spectroscopy can only detect 57Fe (I=1/2), which is 2% 
naturally abundant. Thus, samples analyzed via MB must be enriched in this specific iron 
isotope. Gamma radiation is supplied by a radioactive 57Co source, which releases a 14.4 
keV photon that is absorbed by 57Fe nuclei in samples. This energy induces a nuclear 
transition from a ground state (I=1/2) to the first excited state (I=3/2). There are six 
allowed transitions for 57Fe nuclei dictated by the selection rules for Mössbauer.160 MB 
can detect individual iron centers in isolated proteins. MB can also resolve groups of iron 
species in whole cells or isolated organelles. Examples of such groups include high-spin 
(HS) and low-spin (LS) hemes, oxidized and reduced ISCs, mononuclear non-heme FeII 
and FeIII species, and ferric oxyhydroxide nanoparticles (NP). 
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Groups of Fe species are distinguished in MB spectra by spectral patterns along 
with unique parameters called isomer shift (d) and quadrupole splitting (DEQ). Common 
spectral patterns include a two-line quadrupole doublet and a six-line sextet. The former 
arises due to an interaction between a quadrupole moment and an electric field gradient 
(EFG), while the latter occurs because of magnetic hyperfine splitting. The isomer shift 
(d) corresponds to the deviation (positive or negative) of the MB transition from zero 
velocity in a given spectra. This parameter is based on the difference of s-electron density 
in the nucleus and contributes valuable information regarding the oxidation state of iron. 
FeII species contain more d electrons than FeIII species, resulting in more shielding and 
less s-electron density in FeII nuclei. In general, ferrous species have larger values of d 
than ferric species. All d values are determined relative to an a-Fe foil calibration standard. 
Quadrupole splitting (DEQ) corresponds to the difference in energy between the two lines 
of a quadrupole doublet and is dependent on the symmetry of an EFG around an iron 
nucleus. The d of quadrupole doublets is measured relative to the midpoint of the two 
spectral lines. The magnitude of DEQ increases when the symmetry of the electronic 
charge distribution decreases. Typically, HS FeII species have larger DEQ values than HS 
FeIII species. This is due to the fact that the electronic structure of a HS FeII system is less 
symmetric than a HS FeIII system, in which there are 5 d electrons equally distributed in 
discrete orbitals. 
There are a few drawbacks associated with Mössbauer spectroscopy. First, the time 
spent collecting Mössbauer spectra is dependent on the level of 57Fe enrichment in 
samples. As a result, samples with low micromolar concentrations may involve 100 – 250 
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hours of data collection. Second, Mössbauer is an expensive technique due to costly prices 
related to operating and maintaining the instruments as well as purchasing radioactive 
sources and pure 57Fe. Lastly, MB is rather esoteric and practical for studying only a 
handful of elements, and in terms of biological systems, it is restricted exclusively to iron 
analyses. 
One of the major strengths of MB spectroscopy is that it detects all the 57Fe in a 
sample, making it extremely effective at examining iron content in complex systems. In 
addition, simulations of MB spectra yield the relative percentages of groups of Fe species. 
Pairing these percentages with the absolute concentration of 57Fe obtained via ICP-MS 
allows for absolute concentrations of groups of Fe species to be determined. MB 
spectroscopy supplies a plethora of chemical information about iron that cannot be 
matched by any other non-disruptive method. 
Low temperature, low field (5 K, 0.05 T) Mössbauer spectra in Chapter IV were 
obtained using a model MS4 WRC spectrometer (SEE Co., Edina, Minnesota). Spectra 
were simulated with WMOSS software and calibrated at room temperature (RT) with a-
Fe foil as described114. Applied magnetic fields were parallel relative to the g-radiation. 
 
EPR Spectroscopy 
Electron paramagnetic resonance (EPR) spectroscopy is an effective and sensitive 
technique for studying species that contain unpaired electrons. Therefore, EPR can be 
applied to detect many transition metals in conjunction with iron. This biophysical tool 
probes for transitions within the ground state spin manifold by sweeping an externally 
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applied magnetic field and using a fixed frequency of microwave radiation. Increasing the 
magnetic field strength results in a linear increase in the energy difference between these 
two states,160 and when the transition energy matches the supplied energy of microwaves, 
resonant absorption occurs. Detected signals in EPR spectra are typically plotted as the 
first derivative of the electronic spin absorption.160 Common paramagnetic species are 
characterized in EPR analysis with signature measurements called g-values. G-values are 
unique proportionality factors that can be calculated from the equation: gbB = hn, where 
b is the Bohr magneton, B is the magnetic field, h is Planck’s constant, and n is the 
frequency of the microwaves. 
Similar to Mössbauer, EPR spectroscopy is useful because it is a non-disruptive 
method of studying biological samples. However, EPR is more sensitive than Mössbauer 
and is capable of detecting half-integer spin systems in the low micromolar concentration 
range. Signals can be quantitated using spin standards with a known concentration and 
analytical software. A major limitation of EPR is that metal species with no unpaired 
electrons, also known as diamagnetic species (S=0), are left undetected in samples. This 
limited coverage of EPR for probing all the iron species in samples like intact cells or 
isolated mitochondria can be somewhat overcome by integrating it with data obtained 
from Mössbauer and UV-Vis analysis. EPR and Mössbauer have synergies such that the 
analysis of a sample can be strengthened significantly when both methods of analysis are 
used. EPR-active iron-containing species will exhibit magnetic hyperfine interactions in 
low-temperature Mössbauer spectra (in the slow-relaxation limit) and a quadrupole 
doublet at high temperature (in the fast-relaxation limit). The EPR spectra can provide 
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crucial parameters used in the spin Hamiltonian such as S, D, and E/D. These same 
parameters can then be assumed when simulating magnetic Mössbauer spectra. 
EPR spectra in Chapter IV were collected at either 4.2 or 10 K using an X-band 
ELEXSYS spectrometer (Bruker Biospin Corp., Billerica, MA). 
 
UV-Vis Spectroscopy 
UV-Vis spectroscopy plays an important role in detecting and quantifying ISCs 
and heme centers, primarily in isolated mitochondria. Heme centers in the reduced form 
exhibit three characteristic bands, termed the a, b, and g (Soret) bands. UV-Vis is able to 
resolve heme a, b, and c based on their unique a band wavelengths, which are ~605, ~565, 
~550 nm, respectively.161 These signature UV-Vis bands disappear whenever the heme 
centers are oxidized. Two different ISCs can be detected using UV-Vis, including [Fe4S4] 
and [Fe2S2], which display distinct features at ~410 and ~430 nm, respectively.162,163 In 
contrast to heme centers, UV-Vis bands of ISCs diminish when the clusters become 
reduced. 
Known extinction coefficients of heme a, b, and c can be used to calculate the 
concentrations of individual heme components.164 The major advantage of UV-Vis 
spectroscopy is its ability to resolve each of these heme centers. Mössbauer spectroscopy 
is unable to differentiate between low-spin (LS) hemes and [Fe4S4] clusters. Thus, UV-
Vis analysis contributes information regarding heme concentrations that can be integrated 
with Mössbauer and EPR data. A serious limitation of UV-Vis spectroscopy is its poor 
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coverage of different iron species. Many iron centers are left undetected in UV-Vis spectra 
and is the main reason why UV-Vis can only be utilized as a complementary method. 
UV-Vis spectra in Chapter IV were recorded at RT under anaerobic conditions 
using a Hitachi U-3310 spectrometer (Tokyo, Japan) equipped with a Head-on 
photomultiplier tube. 
 
Inductively Coupled Plasma Mass Spectrometry 
ICP-MS is an effective analytical tool that is used to measure highly accurate metal 
concentrations in whole cells and isolated mitochondria. This technique is very sensitive 
and is able to detect most elements including transition metals in concentrations as low as 
10 parts per trillion (ppt). This low detection limit makes it suitable for quantifying the 
trace metal content in complex biological systems, such as tissues, cells, and organelles. 
This method also has a large dynamic linear range with an upper detection limit in the 
high parts per million (ppm). ICP-MS is able to rapidly analyze a broad spectrum of 
elements and has detection limits that are 100-fold better than optical emission techniques. 
Detection via ICP-MS is based on mass which makes it useful for distinguishing different 
isotopes of a given element (e.g., 56Fe and 57Fe). However, despite its utility ICP-MS is 
unable to differentiate between oxidized and reduced forms of metal species. 
ICP-MS is used in these studies for its ability to quantify metal content in 
biological samples. More importantly, ICP-MS is able to quantify total concentrations of 
57Fe in whole cells or isolated mitochondria, which can complement data obtained from 
Mössbauer analysis. As discussed previously, Mössbauer requires samples to be enriched 
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with 57Fe. Since 57Fe is the only iron isotope that is detected by Mössbauer, percentages 
of iron species in simulations can be used for estimating absolute concentrations of such 
species in samples. Results obtained by ICP-MS analysis are useful for characterizing iron 
phenotypes in mutant strains. Thus, ICP-MS can be utilized in two different capacities: as 
a precise tool for determining metal content in complex sample matrices and as a mutli-
element detector when connected to an LC setup. 
 
Application of LC-ICP-MS System for Bioanalytical Studies 
Bioanalytical studies were conducted using a liquid chromatography (LC) system 
interfaced with an online inductively coupled plasma mass spectrometer (ICP-MS). The 
LC-ICP-MS system was utilized to study LMM metal complexes (< 10 kDa) in 
mitochondrial extracts. Separation of LMM complexes by size-exclusion chromatography 
(SEC) was achieved with two Superdex peptide columns, which were suitable for 
resolving peptides and nonproteinaceous metal species with masses between 0.2 and 10 
kDa. This setup was able to fractionate LMM complexes by molecular weight. Metal 
complexes that eluted from the LC column were directed into the ICP-MS for detection. 
Approximate masses of detected complexes were estimated by calibrating size-exclusion 
columns with a series of standards (Figure II-1 and Table II-1). 
The online LC-ICP-MS system was not only optimized to identify endogenous 
LMM metal species but also to isolate and preserve them for downstream characterization 
methods. Eluate could be split so that a small portion was sent to the ICP-MS for metal 
analysis while the remainder was sent to a fraction collector. This experimental setup was  
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Figure II-1. Calibration curve for determining molecular masses based on the 
migration through the size-exclusion column. Open circles represent the compounds 
listed in Table II-1. The best-fit line through the data (solid line) has a slope of -1.142 and 
an intercept of 5.473. The R2 for the fit was 0.966, and V0 was 15.32 mL. 
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Table II-1. Compounds used for calibrating the size-exclusion columns. V0 
determined to be 15.3 mL using Blue Dextran (Fisher Sci.). afrom a previous study.158 
 
  
Compound Source Method of Detection 
Molecular 
Weight 
(Da) 
Log(MW) 
Elution 
Volume 
(mL) 
Ve/Vo 
Pi  
(PO43-) 
Fisher Sci. ICP-MS (P) 95 1.978 44.8 2.92 
       
Molybdate 
(MoO43-) 
Sigma 
Aldrich ICP-MS (Mo) 159 2.201 44.1
a 2.88 
       
Glutathione 
(GSH) 
Sigma 
Aldrich ICP-MS (S) 307.32 2.488 42.5
a 2.77 
       
AMP Fisher Sci. ICP-MS (P) 347 2.540 41.8a 2.73 
       
ADP Fisher Sci. ICP-MS (P) 427.2 2.631 38.0a 2.48 
       
ATP Fisher Sci. ICP-MS (P) 507.18 2.705 36.5 2.38 
       
Oxidized Glutathione 
(GSSG) 
Sigma 
Aldrich ICP-MS (S) 614.64 2.789 33.8 2.21 
       
Inositol 
Hexaphosphate 
Sigma 
Aldrich ICP-MS (P) 660 2.820 34.1
a 2.22 
       
Cyanocobalamin Fisher Sci. ICP-MS (Co) 1,355  3.132 32.5 2.12 
       
Insulin 
(equine) Fisher Sci. UV (280 nm) 5777 
 3.761 23.7a 1.55 
       
Cytochrome C 
(S. cerevisiae) 
Sigma 
Aldrich  ICP-MS (Fe) 12,384
 4.093 19.2 1.25 
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novel because the entire system, excluding the ICP-MS, was encapsulated inside a 
refrigerated anaerobic N2-atmosphere glove box (≤ 5 ppm O2, 10˚C). This approach was 
pioneered to prevent the oxidation of metal centers and to reduce the rate of ligand-
exchange and only applied to metal species that did not decompose during the course of 
the experiment. Evidence of decomposition would include chromatograms exhibiting 
peaks that correspond to masses of aqueous (“free”) metal ions (<200 Da). 
 
Chemicals, Buffers, and Standards 
Deionized (DI) water was prepared using a Barnstead B-Pure™ water purification 
system. High purity double-distilled-and-deionized (DDDI) water was generated using a 
Teflon sub-boiling still (Savillex DST-1000). DI water was used to prepare media and 
mitochondrial isolation buffers, while DDDI water was used in LC running buffers and 
any experiments involving ICP-MS. 57Fe metal powder was purchased from Isoflex (San 
Francisco, California). Ar (99.998%), N2 (99.999%), and O2 (99.6%) compressed gas 
cylinders were purchased from Praxair (Bryan, Texas). 
For mitochondrial isolations, the following buffers were used: SP buffer (1.2 M 
sorbitol, 20 mM KH2PO4, 1 mM EGTA, pH 7.4); Tris buffer (100 mM Tris-HCl, 1 mM 
EGTA, pH 9.4); SH buffer (0.6 M sorbitol, 20 mM HEPES, 1 mM EGTA, pH 7.4); PBS 
buffer (137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, pH 7.4); and mitochondrial 
isolation buffer, or MIB, (225 mM D-mannitol, 75 mM sucrose, 5 mM HEPES, 1 mM 
EGTA, and 1 mM PMSF, pH 7.4). Regarding online LC-ICP-MS experiments, two 
running buffers were used: 50 mM Tris-HCl (pH 7.4) in Chapter III and 20 mM 
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ammonium bicarbonate (pH 8.5) in Chapter IV. All buffers were degassed on a Schlenk 
line and purged with 99.998% Ar gas for at least 3 cycles immediately prior to use. 
Primary and secondary elemental calibration standards used in offline ICP-MS 
concentration analysis were obtained from Inorganic Ventures (Christiansburg, Virginia). 
Size-exclusion columns used in LC-ICP-MS analysis were calibrated with a series of 11 
known standards (Table II-1). Sodium phosphate (PO43-), adenosine-5’-monophosphate 
(AMP) disodium salt, adenosine-5’-diphosphate (ADP) monosodium salt, adenosine-5’-
triphosphate (ATP) disodium salt, cyanocobalamin, and insulin (equine) were purchased 
from Fisher Scientific (Pittsburgh, Pennsylvania). Cytochrome c (Saccharomyces 
cerevisiae), inositol hexaphosphate, oxidized glutathione (GSSG), reduced glutathione 
(GSH), and sodium molybdate (MoO43-) were purchased from Sigma Aldrich (St. Louis, 
Missouri). 
 
Yeast Strains and Media 
Saccharomyces cerevisiae strain BY4741 (MATα, ura3Δ0, leu2Δ0, met15Δ0, 
his3Δ1) was used in Chapter III of this dissertation. Wild-type (WT) BY4741 cells were 
grown on standard yeast peptone agar plates with 2% glucose (YPD) for 3–4 days. YPD 
plates consisted of 2% glucose, 2% Bacto peptone, 2% Bacto agar, and 1% yeast extract 
(percentages in w/v). Colonies were inoculated into minimal medium containing 2% (w/v) 
glucose, 5 g/L ammonium sulfate, 1.7 g/L YNB (lacking ammonium sulfate and copper 
sulfate), 100 mg/L leucine, 50 mg/L adenine hemisulfate dihydrate, 20 mg/L uracil, 
20mg/L histidine, 20 mg/L methionine, and 50 mg/L tryptophan. The endogenous metal 
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ion concentrations of minimal medium were: 10 µM Zn, 2 µM Mn, 2 µM Co, 0.3 µM Fe, 
0.2 µM Cu, 5 nM Mo (n=2). For standard growth, CuII sulfate and 57FeIII citrate were 
added to the medium to final concentrations of 1 and 10 µM, respectively. In two metal 
supplementation experiments, 10 µM CuII sulfate or 100 µM FeIII citrate was added to 
standard medium. In two other supplementation experiments, 100 µM Zn(acetate)2 or 20 
µM MnCl2 (final concentrations) was added. 
The Mrs3/4 double-deletion (DD) mutant strain used in Chapter IV was derived 
from a WT S. cerevisiae W303 strain (MATa, ura3-1, ade2-1, trp1-1, his3-11, 15, leu2-3, 
112). Deletion of MRS3 and MRS4 in the D∆ strain was confirmed via PCR analysis 
(Figure II-2). WT and DD cells were grown on YPAD agar plates for 3 days at 30 ºC. 
YPAD plates consisted of 2% glucose, 2% Bacto peptone, 2% Bacto agar, 1% yeast 
extract, and 0.01% adenine (percentages in w/v). Cells were taken from plates and grown 
under respiring conditions in liquid minimal medium containing 3% (v/v) glycerol, 1% 
(v/v) ethanol, 5 g/L ammonium sulfate, 1.7 g/L YNB (lacking ammonium sulfate and 
copper sulfate), 100 mg/L leucine, 50 mg/L adenine hemisulfate dihydrate, 20 mg/L 
histidine, 20 mg/L uracil, 50 mg/L tryptophan, and 1 µM copper sulfate. A 40 mM stock 
solution of 57FeIII citrate (pH ~5) was prepared as described (1) and added to the growth 
medium to achieve final concentrations of 1, 10, and 40 µM. For BPS-treated medium, 
bathophenanthrolinedisulfonic acid (BPS), a strong FeII chelator, was added to a final 
concentration of 25 µM, followed by supplementation with 1 µM (final concentration) 
57FeIII citrate. Taking into account the endogenous [Fe] in minimal medium was ~7 µM,  
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Figure II-2. Verification of Mrs3/4 double-deletion (DD) yeast strain. Agarose gel 
(2%) of WT cell extract (left image) and DD cell extract (right image). DNA was extracted 
from 50 mL cultures grown on minimal medium containing 40 µM Fe and harvested at 
OD600= 0.8. Left image: Lane 1, DNA ladder with the sizes (in bp) of relevant markers 
indicated on the side; Lane 2, blank; Lane 3, MRS3; Lane 4, MRS4. The bands at ~800 bp 
correspond to the PCR products of WT DNA (MRS3 and MRS4). Right image: Lane 1, 
DNA ladder; Lane 2, blank; Lane 3, DMRS3; Lane 4, DMRS3 (twice as much loaded as in 
Lane 3); Lane 5, blank; Lane 6, DMRS4 (same amount loaded as in Lane 4). The bands at 
~500 bp correspond to the PCR products of DD DNA (DMRS3 and DMRS4). 
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this afforded a molar excess of BPS. All yeast strains were generously provided by Dr. 
Andrew Dancis (University of Pennsylvania) and stored at -80˚C in YPAD medium 
containing 15% glycerol. 
 
Growth and Preparation of Whole Cell Samples 
Growth of yeast cells was monitored by measuring optical density at 600 nm 
(OD600) with a Thermo Spectronic Genesys 6 spectrophotometer (Thermo Electronic 
Corporation, Waltham, MA). For all yeast experiments, frozen cell stocks were streaked 
out on YPAD plates and incubated for 3 days at 30˚C. Single colonies were inoculated 
into 50 mL of minimal medium. At OD600= 0.8 ± 0.1, 50 mL cultures were transferred into 
1 L of minimal medium. 50 mL and 1 L cell cultures were grown in baffled flasks at 30˚C 
with constant shaking. Growth curves shown in Chapter IV were obtained by recording 
OD600 values of 1 L cultures at various time points starting from the time of inoculation 
(t=0) until cells reached stationary phase. 
For yeast mitochondrial isolations, 1 L cell cultures (OD600= 0.8) were used to 
inoculate 24 L of minimal medium in a custom-built iron-free glass/titanium water-
jacketed bioreactor with O2 gas bubbled through the medium (~1 L/min) and a 
temperature-controlled water-jacket set at 30˚C. For most batches, cells were harvested in 
exponential growth phase at OD600= 0.8 (1 cm pathlength). Other batches were harvested 
at OD600= 1.2 – 1.6 when cells were transitioning into postexponential growth mode. At 
the start of each harvest, the bioreactor was set to 5˚C.  
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Whole cell samples were prepared aerobically. When cells reached OD600= 0.8, 1 
L cultures were centrifuged at 5000g for 5 minutes (Sorvall Evolution RC centrifuge, 
SLC-6000 rotor). Cells were washed 3´ with unbuffered 1 mM EGTA and then 3´ with 
distilled water. Cells were subsequently packed into EPR tubes and Mössbauer cups and 
frozen in liquid nitrogen (N2) for further biophysical analysis. 
 
Isolation of Mitochondria 
At OD600= 0.8, 24 L cultures of yeast cells were transferred into numerous 1 L 
centrifuge bottles using a transfer line and peristaltic pump and pelleted at 5000g for 5 
minutes (Sorvall Evolution RC centrifuge, SLC-6000 rotor). Supernatants were discarded, 
and cell pellets were resuspended in distilled (DI) water using a rubber policeman. 
Resulting cell suspensions were consolidated into one centrifuge bottle. This bottle was 
centrifuged at 5000g for 5 minutes. The supernatant was discarded, and the weight of the 
cell pellet was measured and recorded. Typically, a 24 L culture at OD600= 0.8 yielded a 
~50 g cell pellet. The centrifuge bottle containing the weighed cell pellet was brought into 
an anaerobic glove box (~5 ppm O2, 5˚C) unsealed. The cell pellet was resuspended in 
~500 mL of degassed Tris buffer (pH 9.4) inside the glove box. Dithiothreitol (DTT) was 
brought into the glove box, dissolved in ~10 mL of Tris buffer, and immediately added to 
the cell suspension to a final concentration of 10 mM. For a 500 mL solution, this required 
0.7708 g of DTT. Once the DTT was added, the resulting suspension was sealed tightly, 
removed from the glove box, and incubated inside a rotary shaker at 30˚C for 12 minutes. 
Cells were then pelleted at 5000g for 5 minutes and brought inside the glove box. The 
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supernatant was discarded, and the cell pellet was resuspended with ~500 mL of degassed 
SP buffer (pH 7.4). The centrifuge bottle was removed from the glove box and centrifuged 
at 5000g for 5 minutes. Cells were brought into the glove box, and the supernatant was 
discarded. The cell pellet was then resuspended in SP buffer (~500 mL) and a 1 mL aliquot 
of the resulting cell suspension was removed and placed in an Eppendorf tube. Lyticase 
(Sigma-Aldrich, L2524) was brought into the glove box, dissolved in ~10 mL of SP buffer, 
and immediately added to the cell suspension. The amount of lyticase added (in units of 
mg) was based off the mass of the cell pellet and calculated using the following formula:  
mg of lyticase = (mass of cells in g) ´ (1000 U/g of cells) ´ (mg of lyticase/3949 U) 
After the addition of lyticase, a 1 mL aliquot of the cell suspension was pipetted 
into an Eppendorf tube. Cells were removed from the glove box and incubated in a rotary 
shaker at 30˚C until spheroplasts formed. Aliquots taken before and after the addition of 
lyticase were used to monitor the formation of spheroplasts. Spheroplast formation was 
indicated by a 20 – 30% decrease in OD600 of 1:100 dilutions of lyticase-treated cells in 
water. Typically, a 20 – 30% decrease was reached in 1 – 2 hours. Following this decrease, 
spheroplasts were centrifuged at 5000g for 5 minutes and brought inside the glove box. At 
this stage, the spheroplast should be loose and handled gently. The supernatant was 
discarded and the spheroplast pellet was resuspended with SP buffer (~500 mL). The cell 
suspension was removed from the glove box and centrifuged at 5000g for 5 minutes. 
Spheroplasts were brought into the glove box, and the supernatant was discarded. The 
spheroplast pellet was resuspended in a 1:1 solution of degassed 2xSH buffer (pH 7.4) and 
H2O containing 1 mM PMSF. In general, 100 mL of 2xSH was added first, followed by 
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100 mL of H2O containing 1 mM PMSF. The resulting suspension (~200 mL) was 
homogenized inside the glove box using 25 strokes from a Dounce homogenizer (Type B 
pestle), which could only accommodate ~40 mL of spheroplast suspension. Thus, 5 – 6 
rounds of homogenization were required. Homogenates were placed into a 250 mL 
centrifuge bottle, sealed tightly, and removed from the glove box. Homogenates were 
pelleted at 2000g for 5 minutes (GSA rotor) to remove cell debris. The pellet formed from 
this centrifugation was extremely loose and required delicate handling. The centrifuge 
bottle was brought inside the glove box, and the supernatant was retained in another 250 
mL centrifuge bottle. The cell debris pellet was resuspended in ~150 mL of degassed SH 
buffer (pH 7.4). The resulting suspension was homogenized using only 10 strokes, 
removed from the glove box, and centrifuged at 2000g for 5 minutes. The centrifuge bottle 
was brought into the glove box, and the supernatant was combined with the supernatant 
from the previous homogenization step. The pooled supernatants were taken out of the 
glove box and centrifuged at 12000g for 10 minutes. The resulting pellet was referred to 
as “crude” mitochondria and was handled delicately. The centrifuge bottle was brought 
inside the glove box, and the supernatant was discarded. “Crude” mitochondria were 
resuspended in a ~10 mL of SH buffer and gently layered on top of discontinuous density 
gradients. Each density gradient was composed of 10 mL of 14.5% (w/v) Histodenz 
overlayed on top of 10 mL of 18.5% (w/v) Histodenz. Both solutions of Histodenz were 
prepared using SH buffer. Typically, 4 – 6 density gradients were made, and the “crude” 
mitochondrial suspension was distributed equally among them (roughly 2 – 3 mL of crude 
suspension per gradient). After crude mitochondria were pipetted onto density gradients, 
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they were sealed in ultracentrifuge inserts and removed from the glove box. Density 
gradients were spun at 150,000g for 1 hour in a Beckman Coulter Optima 90K 
ultracentrifuge (SW 32 Ti rotor). Ultracentrifuge inserts were brought into the glove box, 
and the less dense material floating at the top of gradients was removed with a glass pipette 
and discarded. Mitochondria were collected at the interface between the 14.5 and 18.5% 
Histodenz solutions using a glass pipette and placed in a new ultracentrifuge tube. 
Mitochondria were rinsed with 5 – 10 mL of SH buffer, sealed in an ultracentrifuge insert, 
and removed from the glove box. Mitochondria were pelleted in the ultracentrifuge at 
12000g for 10 minutes. The insert was brought back into the glove box, and the resulting 
pellet was referred to as isolated mitochondria. 
In Chapter IV, isolated yeast mitochondria were packed into EPR tubes or 
Mössbauer cups and frozen in liquid N2 for subsequent analysis as described.165 For UV-
Vis studies, mitochondrial EPR samples were thawed anaerobically inside a glove box. 
Once thawed, samples were transferred into 3.5” EPR tubes and placed in ultracentrifuge 
inserts before being removed from the glove box. Mitochondrial samples were pelleted in 
the ultracentrifuge (SW 32 Ti rotor) at 12000g for 10 minutes. Samples were brought into 
the glove box and diluted 1:1 with SH buffer and transferred to custom 2 mm path length 
quartz UV-Vis cuvettes (NSG Precision Cells, Inc., Farmingdale, New York). Volumes 
of packed mitochondria were determined as described.165 Cuvettes were sealed with a 
rubber septum and removed from the glove box for UV-Vis analysis. 
Human Jurkat cells were grown on 10 µM FeIII citrate, and mitochondria were 
anaerobically isolated as described.166 Briefly, Jurkat cells were washed with PBS buffer 
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(pH 7.4) containing 1 mM EGTA, resuspended in mitochondrial isolation buffer (pH 7.4), 
and lysed by nitrogen cavitation. Cell lysate was strained, followed by centrifugation 
(Sorvall Evolution RC centrifuge, SLC-6000 rotor) at 800g for 10 minutes. Supernatant 
was saved and centrifuged at 9000g for 30 minutes. The mitochondrial pellet was 
resuspended in ~2 mL of MIB and pipetted on top of four Histodenz density gradients. 
Each gradient was composed of 3 mL of 35% Histodenz, 3 mL of 17% Histodenz, and 7.5 
mL of 5% Histodenz. All Histodenz solutions were prepared using MIB. Density gradients 
were spun in an ultracentrifuge at 45000g for 1 hour (SW 32 Ti rotor). Mitochondria were 
pipetted from the 17-35% Histodenz interface and washed with MIB and frozen in liquid 
N2. This sample was thawed anaerobically inside a glove box and injected into the online 
LC-ICP-MS system. 
C57BL/6 mice were raised, and organs were dissected as described.167 
Mitochondria isolated from mouse brain and liver tissues used in Chapter III were 
prepared as described.168 Samples were retrieved from liquid N2 dewars, thawed 
anaerobically inside a glove box, and subjected to LC-ICP-MS analysis. 
 
Preparation of LMM Mitochondrial Flow-Through Solutions 
Isolated mitochondria were washed two or three times in 50 mM Tris (pH 7.4). For 
yeast and mammalian mitochondria, 82% and 65% of the packed volume of the isolated 
organelle were previously determined to be due, respectively, to the mitochondria 
themselves.165,169 Assuming these packing efficiencies, pellets were resuspended in 1.0 
mL of the same buffer but with 2% Triton X-100. This typically afforded a final volume 
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of 1.4 mL.  After being incubated for 15 min while being constantly vortexed, the solution 
was centrifuged at 12000g for 15 min. The resulting supernatant, called the soluble 
mitochondrial extract (SME), typically constituted all but ~50 µL of the solution volume. 
The SME was transferred to an Amicon stirred cell concentrator containing a 10 kDa 
cutoff membrane, and the flow-through solution (FTS) was collected. Relative to 
concentrations in intact isolated yeast mitochondria, both SME and FTS were typically 4 
times more dilute [1.4/(0.4×0.82) ≈ 4]. 
For each batch, 75 µL aliquots of the SMEs and FTSs were placed in 15 mL nitric 
acid-rinsed screw-capped polypropylene tubes. Samples were incubated with 100 µL of 
concentrated trace metal grade nitric acid, sealed with plastic electrical tape, digested for 
12 h at 90˚C, and then diluted with water to 10 mL. Resulting solutions were analyzed by 
ICP-MS. Concentrations were calibrated using primary P, S, Mn, 56Fe, 57Fe, Co, Cu, and 
Zn standards (Inorganic Ventures, 5000 µg of metal/L each). Secondary standards (0, 10, 
50, and 100 µg/L for each metal and 0, 1000, 5000, and 10000 µg/L for P and S) were 
used for calibration. 
LC-ICP-MS experiments were performed in a refrigerated anaerobic glove box 
(MBraun Labmaster) at 10˚C and ~5 ppm of O2. FTSs (500 µL) were injected onto two 
10 ´ 300 mm Superdex peptide columns (GE Healthcare Life Sciences, Product No. 
17517601) connected in series. The resulting double-length column was equilibrated with 
50 mM Tris-HCl (pH 7.4) in Chapter III and 20 mM ammonium bicarbonate (pH 8.5) in 
Chapter IV. After injection, the running buffer was pumped through the column at a rate 
of 0.350 mL/min for 166 min using an Agilent Bioinert high-performance liquid 
  51 
chromatography system (Tokyo, Japan) with titanium pump heads and all-PEEK tubing. 
The total elution volume (58 mL) corresponded to 2 column volumes (CVs), as determined 
using Blue Dextran. The eluent passed through a diode array UV-vis detector and into the 
nebulizer of an Agilent 7700x ICP-MS. The ICP-MS detected 31P, 34S, 55Mn, 56Fe, 57Fe, 
59Co, 63Cu, 66Zn, and 95Mo in He collision mode with a dwell time of 0.1 s. After every 
other run, columns were cleaned with 10 CVs of a chelator cocktail.158 
The metal concentration corresponding to each peak in the chromatograms was 
determined as follows. The column was replaced with tubing, and 500 µL of the same 
elemental standards were injected onto the “phantom column”. The resulting “eluent” 
flowed into the ICP-MS, affording a chromatogram, for each element, composed of a 
single peak. Each area:concentration ratio was obtained by dividing the integrated areas 
under the peak by the concentration of the standard injected. 
A second method for determining metal concentrations was also used to evaluate 
the fraction of metal ions that adsorbed onto the column. Areas associated with each peak 
were determined by fitting. Each peak area was divided by the sum of all areas in the 
chromatogram. The resulting fractions reflected the proportion of each metal associated 
with a particular peak. The sum of these areas was assumed to correspond to the total 
concentration of the metal in the FTS.  
If no metals adsorbed onto the column during a run, the concentrations obtained 
by the second method would equal those obtained by the first. In practice, the two differed 
by <10%, indicating that the vast majority of the metals in the FTSs eluted from the 
column. 
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ESI-MS Experiment 
Mitochondria were isolated from cells grown on medium containing an 
approximate 1:1 molar ratio of 56Fe:57Fe (40 µM total). FTS (500 µL) was injected onto 
two Superdex peptide columns connected in series, and the eluent (flow rate = 0.35 
mL/min) was split via a micro splitter valve (Upchurch Scientific, USA) with ~30% 
directed to the ICP-MS and ~70% directed to an Agilent 1260 Infinity Analytical-scale 
Fraction Collector (Agilent, Tokyo, Japan). 700 µL fractions were collected in 96 Deep 
Well plates, and those selected for ESI-MS analysis were anaerobically frozen in liquid 
N2. ESI-MS spectra were acquired in positive ion mode using an Orbitrap Fusion Tribrid 
mass spectrometer (Thermo Scientific) equipped with a HESI source. Sample was injected 
at 5 µL/min, and the spray potential was set to 3 kV. Sheath gas, Aux gas, and Sweep gas 
were set at 3, 2, and 1 (arbitrary units), respectively. Acquired ESI-MS data was 
interrogated using Thermo Excalibur software. 
 
Metal Concentration Analysis 
Metal concentrations of whole cells or isolated mitochondria in Chapter IV were 
analyzed by offline ICP-MS (Agilent Model 7700x). After collecting Mössbauer spectra, 
samples were thawed and packed into EPR tubes to measure sample volumes (ca. 200 – 
300 µL) and then diluted with 250 µL of high purity DDDI water. 50, 75, and 100 µL 
aliquots from the resulting suspensions were transferred to 15 mL screw-top 
polypropylene Falcon tubes, digested with 250 µL of concentrated trace metal grade nitric 
acid, and heated overnight (~16 hours) at 90˚C. Digested samples were diluted with high 
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purity DDDI H2O to a final volume of 8.0 mL. Reported metal concentrations of whole 
cells and mitochondria were calibrated as described and corrected using previously 
reported packing efficiencies of 0.70 for whole cells and 0.77 for mitochondria. 
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CHAPTER III 
DETECTION OF LABILE LOW-MOLECULAR-MASS TRANSITION METAL 
COMPLEXES IN MITOCHONDRIA* 
 
Introduction 
Many transition metal complexes are labile, meaning that their coordinating 
ligands are weakly bound and rapidly exchanging with other ligands in solution. This 
behavior adds a significant challenge to the isolation, identification, and characterization 
of such labile metal pools (LMPs) in cells.170 These pools have been detected by 
incubating live, intact cells with custom-designed fluorescence-based chelators, also 
known as sensors or probes.171 Chelator probes penetrate cell membranes and coordinate 
the metal ions that compose such pools; they can also be targeted to specific organelles 
within the cell. Binding metal ions either enhances or quenches the fluorescence properties 
of the probes, thereby reporting on the existence and size of such pools. 
The use of chelator probes has dramatically improved our awareness of LMPs in 
cells, yet many details, including the composition, structure, and function of the metal 
pools, remain unknown. LMPs likely participate in metal ion trafficking, regulation, 
signaling, and storage and release. Such processes require that metals coordinate ligands 
weakly enough such that the metals can be transferred from one species to another, or that 
                                                
* Reproduced with permission from Sean P. McCormick, Michael J. Moore, and Paul A. 
Lindahl (2015) Detection of Labile Low-Molecular-Mass Transition Metal Complexes 
in Mitochondria, Biochemistry 54, 3442–3453. Copyright 2015 American Chemical 
Society. 
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the metals can dynamically bind to regulatory sites in a concentration-sensitive manner. 
These processes play vital roles in metal ion metabolism and are often altered in metal-
associated diseases. These considerations motivate our efforts to identify and characterize 
LMPs, the challenges associated with their lability notwithstanding. 
The benefits of detecting LMPs in live, intact cells and organelles using 
fluorescence-based probes are counterbalanced by the fact that the sought-after complexes 
are destroyed during detection; i.e., the endogenous ligands associated with LMPs 
dissociate when the probe coordinates the metal. This is a major disadvantage because the 
ligand environment dictates many properties of these complexes. Also, the binding 
strength required to chelate a particular metal ion pool is unknown such that stronger 
probes might overestimate the size of a pool and weaker ones might underestimate it. 
LMPs may be heterogeneous, with more than one metal complex contributing. Probes are 
often championed as being specific for a particular metal ion, but they actually need to be 
specific for a particular metal ion complex, a far more difficult requirement. Deciphering 
the molecular-level function of each complex that composes a heterogeneous LMP based 
solely on the overall chelation properties of the pool seems virtually impossible. 
Ligand-exchange rates of LMPs are likely to be fast, but if they were faster than 
the rates of relevant biochemical reactions, e.g., binding of a complex to a receptor, the 
complexes would lack a defined shape, a requirement of receptor recognition. With such 
extreme fluxionality, how could cells use such complexes in trafficking, regulation, 
signaling, or storage? Would not their coordination sites become available for deleterious 
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Fenton and Haber-Weiss reactions? Should not there have been a selective advantage to 
minimize such chaos? 
Motivated by these considerations, we hypothesized that the rates of ligand 
exchange associated with LMPs are actually slow enough for individual metal complexes 
to be isolated. Perhaps exchange rates have been reduced during evolution by the use of 
polydentate ligands and donor atoms that afford relatively strong metal-ligand binding 
interactions. 
With the goal of isolating labile metal complexes, we have designed a refrigerated 
anaerobic liquid chromatography system interfaced with an online inductively coupled 
plasma mass spectrometer. Our LC-ICP-MS system can split a portion of the eluent to the 
ICP-MS for detection and send the remainder to a fraction collector. This arrangement 
allows us to detect, isolate, and eventually characterize the complexes that compose 
LMPs. 
In this study, we have focused on LMPs in mitochondria isolated from fermenting 
Saccharomyces cerevisiae cells. LMPs were assumed to be composed of metal complexes 
with masses of <10 kDa, rationalized as follows. Most mitochondrial metalloproteins are 
encoded by nuclear DNA and imported into mitochondria as unfolded polypeptides 
threaded through the TOM/TIM protein complexes on the outer and inner membranes 
(OM and IM, respectively).172 Once in the matrix, a signal sequence is typically clipped, 
and the apo-metalloprotein folds and is metalated. Metalloproteins encoded by mtDNA 
are probably metalated by similar mechanisms. In either case, most of the metal ions used 
in metalation must be transported into the matrix. Because the IM is “tight,” these metal 
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ions must enter the matrix through channel-containing IM transport proteins, thereby 
excluding high-molecular-mass (HMM) species.3,88 Metal donors must be small enough 
to pass through pores in the OM, which is limited to masses of less than ~3 kDa.173 
Metalloproteins that localize to the IMS might be metalated by metal complexes that enter 
the IMS via the OM.28 However, the Cu ions that metalate IMS metalloproteins have been 
proposed to pass from the cytosol to the matrix and then to the IMS.157 
Here we report detection of LMM P, S, Mn, Fe, Co, Cu, Zn, and Mo species, some 
of which probably function to metalate mitochondrial apo-metalloproteins. We assessed 
the reproducible occurrence of such species, determined their approximate molecular 
masses, and estimated their concentrations within the organelle. Our results set the stage 
for more advanced downstream characterizations. 
 
Results 
Five independent batches of mitochondria were isolated from WT yeast cells 
grown on medium supplemented with 10 µM FeIII citrate and 1 µM CuSO4. The cells were 
harvested at a low OD600 of 0.8 during the exponential phase. Aliquots were subjected to 
the LC-ICP-MS system immediately (at t = 0) after mitochondria were isolated. To 
highlight these batch-dependent characteristics (Yeast, Low, t = 0), we will refer to the 
batches as YL0A, YL0B, YL0C, YL0D, and YL0E (Table III-1). Aliquots of YL0A and 
YL0B were re-run after being incubated for 5 days in the glove box; those runs will be 
called YL5A and YL5B. 
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Table III-1. Nomenclature of LC batches. 
 
Batch Name Organism OD600  
at harvest 
Time of  
injection 
Comments 
YL0A Yeast 0.8 Immediately Fermenting 
YL5A Yeast 0.8 5 days later Same batch as YL0A 
YL0B Yeast 0.8 Immediately Fermenting 
YL5B Yeast 0.8 5 days later Same batch as  
YL0B 
YL0C Yeast 0.8 Immediately Fermenting 
YL0D Yeast 0.8 Immediately Fermenting (only  
shown in Figure 6) 
YL0E Yeast 0.8 Immediately Fermenting (not  
shown in Figures) 
YRL0A Yeast 0.8 Immediately Respiring (glycerol) 
(only in Figure III-6) 
YL0Fe Yeast 0.8 Immediately Fermenting 
(extra Fe) 
YL0Cu Yeast 0.8 Immediately Fermenting 
(extra Cu) 
YL0Zn Yeast 0.8 Immediately Fermenting 
(extra Zn) 
YL0Mn Yeast 0.8 Immediately Fermenting 
(extra Mn) 
YH0A Yeast 1.4 Immediately Fermenting 
YH0B Yeast 1.6 Immediately Fermenting 
YH5B Yeast 1.5 5 days later Same batch as  
YH0B 
YH0C Yeast 1.6 Immediately Fermenting 
Brain Mouse From adult 
mice 
Frozen and 
thawed 
See Holmes-Hampton et 
al.167 
Jurkat Human Described 
in Jhurry et 
al.169 
Frozen and 
thawed 
See Jhurry et al.169 
Liver Mouse From adult 
mice 
Frozen and 
thawed 
See Chakrabarti et al.168 
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Four other batches were prepared from WT yeast cells grown on the same medium 
but spiked one at a time with 100 µM Fe, 10 µM Cu, 100 µM Zn, and 20 µM Mn. These 
batches will be called YL0Fe, YL0Cu, YL0Zn, and YL0Mn, respectively. Three other 
batches were harvested at higher culture densities (postexponential phase), including 
YH0A, YH0B, and YH0C. An aliquot of YH0B was re-run 5 days after it was initially 
prepared, generating trace YH5B. A batch prepared under respiring (glycerol) conditions 
will be called YRL0A. Three other batches of mitochondria were prepared, including one 
each from mouse brain, human Jurkat cells, and mouse liver. 
Concentrations of selected elements in isolated mitochondria are listed in Table 
III-2; rounded averages are in Table III-3. Previous studies115,143,174 afforded comparable 
yeast mitochondrial metal concentrations. Concentrations for mammalian mitochondria 
were similar except for that of Mo, which was ~4 times higher than in the yeast organelle. 
Increasing Mn, Fe, Cu, and Zn concentrations 10-fold in the yeast growth medium, one at 
a time, significantly increased the concentration of that element in isolated mitochondria. 
The concentrations of the other detected elements, whose concentrations were not 
increased in the medium, were unaffected. This sensitivity between the medium and 
mitochondrial metal ion concentrations must be mediated by changes in cytosolic metal 
ion levels, but the pathways involved are unknown. The absence of secondary 
perturbations suggests that the homeostatic systems regulating the concentrations of these 
metals in mitochondria are largely independent of each other. 
The concentrations of the LMM forms of these elements in mitochondria are listed 
in Table III-4, with averages again listed in Table III-3. No significant differences between  
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Table III-2. Concentrations of selected elements in isolated mitochondria. Reported 
values are concentrations in SMEs multiplied by dilution factors (average dilution factor 
was 3.5 ± 0.2). Numbers shaded in grey and red were not included in averages (the values 
in grey were high because the medium was supplemented with extra metal; the value in 
red was presumed to be high due to the presence of nanoparticles. Numbers shaded in 
blue, from batches grown to high OD600, were separated from unshaded values in the 
column, from batches grown to low OD600. 
 
Figure 
Legend 
P 
(mM) 
S 
(mM) 
Mn 
(µM) 
Fe 
(µM) 
Co 
(nM) 
Cu 
(µM) 
Zn 
(µM) 
Mo 
(µM) 
YL0A/YL5A 25 5.8 15 420 100 58 290 2 
YH0A 30 6.2 18 750 150 78 380 1 
YL0B/YL5B 26 6.0 16 480 80 54 310 1 
YL0C 25 6.1 15 430 90 48 270 1 
YL0Fe 26 6.2 12 780 80 83 280 2 
YL0Cu 23 6.0 13 410 60 140 240 2 
YL0Zn 28 6.0 14 460 60 35 480 1 
YL0Mn 29 6.0 25 460 50 64 250 2 
YL0D 25 6.1 14 430 90 63 260 1 
YH0B/YH5B 29 6.4 20 720 120 80 360 1 
YH0C 29 6.3 18 770 100 92 340 2 
YL0E 26 6.2 17 410 80 56 280 1 
YRL0A 32 6.8 19 620 110 120 320 2 
Brain 33 7.9 13 380 60 25 210 5 
Jurkat 28 7.9 18 1,000 120 120 220 6 
Liver 34 8.6 16 420 80 21 320 8 
 
  
  61 
Table III-3. Average concentrations of selected elements in mitochondria. The top 
group of rows refers to total mitochondrial concentrations. The second group refers to 
previous reports of metal concentrations in fermenting yeast mitochondria. The third 
group refers to LMM species only. The bottom group indicates the percent of each selected 
element that is found in mitochondria as LMM species (based on data from this study). 
aThe Fe concentration from ref 115 (1190 µM) was excluded. bThe Cu concentration from 
ref 175 (220 µM) was excluded because those cells were grown under respiration 
conditions where cytochrome c oxidase levels are higher. In the Mo column, Y refers to 
yeast and M to mammalian mitochondria. Numbers in the bottom two rows are given as 
percentages, not concentrations. 
 
	 P (mM) 
S 
(mM) 
Mn 
(µM) 
Fe 
(µM) 
Co 
(nM) 
Cu 
(µM) 
Zn 
(µM) 
Mo 
(µM) 
Average  
(HMM+LMM) 28 6.6 16 530 89 71 300 1.4Y;6.3M 
         
Standard Deviation 3 0.9 3 150 27 34 60 0.4Y;1.2M 
         
10-fold M --- --- 25 780 --- 140 480 --- 
         
         
         
Previous Average 
(HMM+LMM)115,143,174,175 --- --- 20 630a --- 70b 280 --- 
         
Standard Deviation --- --- 9 100 --- 28 38 --- 
         
         
         
Average (LMM) 24 5.4 3.1 116 65 32 140 0.02Y;1M 
         
Standard Deviation 3 0.6 1.0 32 18 9 21 5Y;0M 
         
10-fold M --- --- 8 170 --- 120 280 --- 
         
         
         
% LMM 86 82 19 22 73 45 47 1.5Y;16M 
         
Standard Deviation 5 5 6 6 14 20 6 0.9Y;3M 
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Table III-4. Concentrations of selected elements present as LMM species in isolated 
mitochondria. Numbers shaded in grey were not included in averages. Values in tables 
are concentrations of FTSs multiplied by the same dilution factors used in Table III-2. 
 
Figure  
Legend 
P 
(mM) 
S 
(mM) 
Mn 
(µM)  
Fe 
(µM) 
Co 
(nM) 
Cu 
(µM) 
Zn 
(µM) 
Mo 
(nM) 
YL0A/YL5A 20.2 4.8 2 110 55 24 120 20 
YH0A 27.5 5.5 4 120 85 30 160 20 
YL0B/YL5B 21.5 4.9 3 100 45 26 130 30 
YL0C 21.0 5.0 2 120 55 24 120 20 
YL0Fe 21.4 5.3 3 170 72 21 120 20 
YL0Cu 19.7 5.5 2 100 58 120 120 10 
YL0Zn 21.2 5.0 2 120 49 27 280 20 
YL0Mn 23.3 4.9 8 110 45 20 120 20 
YL0D 22.1 5.1 3 110 60 26 120 20 
YH0B/YH5B 24.6 5.4 3 150 95 34 180 30 
YH0C 26.2 5.2 3 160 80 32 160 20 
YL0E 20.6 4.8 2 100 50 28 130 20 
YRL0A 29 5.4 2 150 75 50 160 30 
Brain 26.7 6.3 4 50 50 3 110 1,000 
Jurkat 26.2 6.5 4 110 100 22 110 1,000 
Liver 28.4 6.4 3 60 72 5 120 1,000 
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yeast and mammalian mitochondria were observed except that the average concentration 
of LMM Mo in mammalian mitochondria was 50 times higher than in yeast. 
Approximately 80% of P, S, and Co in mitochondria were LMM, while only 20% of Mn 
and Fe were LMM. Nearly half of the Cu in mitochondria was in the form of LMM 
complexes. However, some LMM Co and Cu may not be physiologically relevant (see 
below), lowering these percentage estimates. In mammalian mitochondria, ~16% of Mo 
in the organelle was present in LMM forms. Nearly half of mitochondrial Zn ions was 
LMM. Atkinson et al.84 reported that nearly half of the Zn in sonicated yeast mitochondrial 
homogenates was soluble; the two results together suggest that most soluble Zn in 
mitochondria is LMM. 
 
LC-ICP-MS Characterization of FTSs 
Mitochondrial FTSs were subjected to anaerobic liquid chromatography. Eluents 
were monitored for LMM P, S, Mn, Fe, Co, Cu, Zn and Mo using an online ICP-MS. The 
abscissas for all chromatograms (Figures III-1 – III-8) were adjusted slightly (±0.3 mL) to 
align two particular phosphorus peaks [Figure III-1, P1000 and P800 (see below)]. Plots of 
all of the other monitored elements in the same run were adjusted identically (i.e., based 
on the P alignment). 
Concentrations of the reproducibly observed LMM species are listed in Table III-
5. HMM peaks were often observed at elution volumes near the void volume (15.3 mL). 
Such peaks were used in concentration determinations but were not analyzed for molecular  
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Figure III-1. Phosphorus chromatograms of LMM mitochondrial FTSs. 
  
  65 
Table III-5. LMM metal complexes and P and S compounds in mitochondria. Values 
were obtained by fitting to Gaussian functions as described in the text.158 ND means not 
detected. The R value indicates the confidence in yeast traces only. 
 
  
Peak 
Name 
Center 
(mL) 
Width 
(mL) 
Molecular  
Mass (Da) 
[yeast] 
(µM) 
[mouse] 
(µM) 
[Jurkat] 
(µM) 
R 
value (%) 
P1000 33.4 ± 0.2 0.9 ± 0.1 1000 ± 200 400 ± 100 500 400 100 
P800 34.6 ± 0.1 1.3 ± 0.2 800 ± 200 300 ± 100 400 400 100 
P520 37.1 ± 0.2 0.7 ± 0.1 520 ± 100 20000 ± 4000 24000 24000 100 
P200 42.7 ± 0.2 1.4 ± 0.1 200 ± 50 230 ± 140 100 100 80 
S1100 32.8 ± 0.3 1.0 ± 0.1 1100 ± 150 4900 ± 40 6300 6300 100 
S780 34.8 ± 0.1 1.4 ± 0.5 780 ± 200 500 ± 400 ND ND 60 
Mn2000 30.5 ± 0.2 1.2 ± 0.1 2000 ± 200 ND 2 3.5 ND 
Mn1100 32.6 ± 0.1 0.9 ± 0.1 1100 ± 160 1.9 ± 0.2 2 0.5 100 
Fe1500 30.8 ± 0.1 0.8 ± 0.2 1500 ± 300 ND 15 ND ND 
Fe1100 32.7 ± 0.1 1.3 ± 0.2 1100 ± 250 6 ± 2 10 ND 80 
Fe870 34.1 ± 0.5 0.7 ± 0.1 870 ± 100 12 ± 9 2 ND 60 
Fe680 35.6 ± 0.4 1.1 ± 0.4 680 ± 130 20 ± 10 2 ND 50 
Fe580 36.6 ± 0.3 1.4 ± 0.1 575 ± 150 90 ± 20 26 110 100 
Fe200 43.3 ± 0.2 1.2 ± 0.8 200 ± 40 2 ± 1 1 ND 90 
Co1500 30.8 ± 0.3 0.8 ± 0.2 1500 ± 300 ND 0.01 0.02 90 
Co1200 32.3 ± 0.2 0.9 ± 0.1 1200 ± 180 0.03 ± 0.02 0.04 0.04 90 
Co840 34.3 ± 0.3 1.7 ± 0.6 840 ± 270 0.02 ± 0.01 0.01 0.02 90 
Co450 38.2 ± 0.5 2.4 ± 0.9 450 ± 200 0.013 ± 0.002  ND ND 70 
Co340 39.8 ± 0.2 1.8 ± 0.4 340 ± 100 0.006 ± 0.004 ND ND 90 
Co300 41.1 ± 0.4 2.0 ± 1.5 300 ± 10 0.002 ± 0.001 ND ND 80 
Cu5000 23.1 ± 0.1 1.4 ± 0.2 5000 ± 1000 16 ± 7 ND ND 90 
Zn1500 30.8 ± 0.2 0.7 ± 0.1 1500 ± 200 ND 8 6 ND 
Zn1200 32.2 ± 0.2 0.6 ± 0.2 1150 ± 100 110 ± 20 100 100 100 
Zn900 34.1 ± 0.1 1.8 ± 1.3 900 ± 300 6 ± 1 ND ND 100 
Mo730 35.0 ± 0.1 0.7 ± 0.1 730 ± 100 ND 0.4 0.3 100 
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mass because the species that migrated in this region were not sufficiently well resolved 
to allow for accurate molecular mass determinations. 
 
Phosphorus 
Yeast mitochondrial FTSs exhibited four major LMM P species with approximate 
masses of 1000, 800, 520, and 200 Da (Figure III-1 and Table III-5). We will refer to these 
as P1000, P800, P520, and P200, respectively. P520 exhibited the greatest intensity, followed 
distantly by P1000, P800, and P200. The concentration of P520 in isolated mitochondria was 
approximately 20 mM. It essentially comigrated with ATP (507 Da). Thus, the majority 
of the P520 peak was assigned to ATP, with ADP (427 Da) thought to contribute to the 
broadening on the low-mass side of the peak. If this is assumed, the concentration of P520 
in mitochondria would be ~7 mM (20/3). Yeast mitochondria reportedly contain 7.8 mM 
ATP.176 This supports our assignment and adds confidence that our methods of estimating 
concentrations and masses were reasonably accurate. 
P1000, P800, and P200 were not assigned. However, the apparent masses of P800 and 
P200 were similar to those of NADPH (744 Da) and pyrophosphate (174 Da). If these 
assignments were correct, the concentration of these species in mitochondria would be 
100 and 200 µM, respectively. Reported concentrations of NADPH in mitochondria and 
cytosol range between 45 and 235 µM,177 which are in the same ballpark. 
The P content of mammalian mitochondria was similar to that of yeast; P520 again 
dominated, and the same minor-intensity species were evident. In the P chromatogram of 
mitochondria from Jurkat cells, the same minor-intensity peaks were present, but their 
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intensities were lower than in the other mammalian samples. The chromatograms of liver 
and brain mitochondrial FTSs exhibited additional P-containing species that were not 
assigned. 
 
Sulfur 
Mitochondrial FTSs consisted of two major S peaks, corresponding to masses of 
1100 and 780 Da (Figure III-2 and Table III-5). S1100 dominated and was reproducibly 
present at concentrations near 5 mM. The presence of S780 was more sporadic. 
Surprisingly, neither species comigrated with glutathione (GSH, 307 Da) or glutathione 
disulfide (GSSG, 612 Da); further studies are needed to explain this given the abundance 
of glutathione in mitochondria. Authentic GSSG migrated in accordance with its mass, 
including in a run of FTS spiked with GSSG. Authentic GSH appears to oxidize as it 
migrates through the column, but the details of this are under investigation. 
 
Zinc 
Yeast mitochondrial FTSs exhibited an intense Zn peak corresponding to a mass 
of 1200 Da (Figure III-3 and Table III-5). The concentration of Zn1200 in yeast 
mitochondria was 110 µM, nearly half of the total Zn in the organelle and almost all of 
the soluble Zn. The same species was in FTSs from mammalian mitochondria. A minor-
intensity species with a mass of ~900 Da (Zn900) was in yeast mitochondria at a 
concentration of ~1 µM. Mitochondria from yeast grown on medium containing 10-fold 
more Zn than normal exhibited a 2.5-fold increase in the intensity of Zn1200 whereas the  
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Figure III-2. Sulfur chromatograms of LMM mitochondrial FTSs. 
 
 
 
 
 
Figure III-3. Zinc chromatograms of LMM mitochondrial FTSs. 
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intensities for the other peaks were not significantly affected. A higher-mass species 
(Zn1500) was detected in mitochondria from brain and liver but not yeast. 
 
Manganese 
A single LMM Mn species with a mass of 1100 Da (Mn1100) dominated the 
chromatograms of fermenting yeast mitochondrial FTSs (Figure III-4 and Table III-5). A 
minority species of higher mass (Mn2000) was in some FTSs. The concentration of Mn1100 
in yeast mitochondria was ~2 µM, while that of Mn2000 was 23-fold lower. The Mn1100 
concentration increased 4-fold in mitochondrial FTS from yeast cells grown in media 
containing 10-fold normal Mn; the concentration of Mn2000 also increased, albeit more 
modestly. 
Both Mn2000 and Mn1100 were in mitochondrial FTSs from human cells and mouse 
tissues, but the relative intensities differed significantly from those in yeast. In 
mitochondria from Jurkat cells, Mn2000 represented ~95% of the Mn in the organelle, with 
minor contributions from Mn1100. The concentrations of these two species in mitochondria 
from mouse brain and liver were more balanced, affording concentrations of 1 – 2 µM 
each. We previously observed a single LMM Mn species in yeast mitochondria with a 
mass between 2000 and 3000 Da.113 Such a species was not observed currently in 
fermenting yeast mitochondria but was observed in our one batch of respiring yeast 
mitochondria (YRL01). A systematic study is required, but we currently suspect 
metabolism-dependent effects. 
 
  70 
 
 
Figure III-4. Manganese chromatograms of LMM mitochondrial FTSs. 
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Iron 
Yeast mitochondrial FTSs exhibited two major Fe species (Fe580 and Fe1100), with 
either species dominating depending on (a) the mode of growth of the cells at the time of 
harvesting and (b) whether the FTS was chromatographed immediately after it was 
prepared or 5 days later. Mitochondrial FTSs isolated from cells harvested during 
exponential growth and run immediately exhibited Fe580 (Figure III-5 and Table III-5). A 
low-intensity peak corresponding to a higher-mass species (Fe1100) was also evident. The 
chromatogram from mitochondrial FTS obtained from cells grown on medium containing 
100 µM FeIII citrate (rather than the standard 10 µM) exhibited a 1.7-fold increase in the 
intensity of the Fe580 peak. 
Fe-detected chromatograms of FTSs isolated from cells harvested during the 
postexponential growth phase and run immediately after isolation were dominated by 
Fe1100. Fe580 was present but at a reduced intensity. Unexpectedly, when a FTS dominated 
by Fe1100 was left in a refrigerated glove box for 5 days, the resulting chromatogram was 
dominated by Fe580, with Fe1100 downgraded to a minor component. In that chromatogram, 
another Fe-containing species with an intermediate mass was also evident. For reasons 
that we don’t understand, trace YL0Mn exhibited a more highly resolved species with a 
mass of 870 Da (Fe870) (Figure III-5). During incubation, Fe1100 may convert into Fe580 via 
intermediate Fe870. The only other Fe species present exhibited a very low intensity peak 
associated with a mass of 200 Da. Because hexaqua Fe has a mass of ~160 Da, we assign 
Fe200 as such. The concentration of Fe200 in our isolated mitochondria samples was 1 – 3 
µM, which we regard as an upper limit of what it might be in intact mitochondria (one- 
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Figure III-5. Iron chromatograms of LMM mitochondrial FTSs. 
  
  73 
half of 1% of the Fe in mitochondria). Fe200 may be an artifact of the isolation procedure, 
with healthy mitochondria devoid of this species. 
Iron chromatograms of FTSs from mitochondria isolated from mammalian cells 
and tissues were similar to those of yeast, but with additional peaks. The chromatogram 
of FTS from mitochondria of Jurkat cells was similar to that of yeast harvested during the 
exponential growth phase, with Fe580 dominating. The chromatogram from mouse tissues 
also exhibited Fe580, but intense peaks corresponding to masses of 2000 and 1200 Da 
(Fe2000 and Fe1200, respectively) were also observed. Fe2000 was not present in yeast 
mitochondria. Fe1200 in mouse mitochondria may or may not correspond to Fe1100 in yeast 
mitochondria; the two migrated near each other, but they did not comigrate. 
Concentrations of Fe2000 and Fe1100/Fe1200 in mammalian mitochondria were ~10 µM each. 
 
Copper 
FTSs from mammalian mitochondria exhibited Cu peaks near or slightly beyond 
the 10 kDa cutoff (Figure III-6, top panel). The observed intensities of Cu species with 
masses of >10 kDa may be less than proportional to their actual concentration in 
mitochondria, as some of these species may have been retained by the cutoff membrane. 
These cutoffs are not exact, such that some proportion of higher-mass Cu species also 
passes into the FTS, as observed. Also, our size-exclusion column has some resolving 
power beyond 10 kDa. For example, cytochrome c (Table II-1, 12384 Da) fell nicely on 
the calibration line (Figure II-1), although its mass is beyond the formal resolving limit of 
the column. Thus, a Cu complex with a mass of ~13 kDa would be detected and resolved  
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Figure III-6. Copper chromatograms of LMM mitochondrial FTSs. 
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by our experiment; indeed, such features are observed in FTSs from mammalian 
mitochondria. 
The region between 10000 and 2000 Da exhibited the greatest reproducibility 
(Figure III-6, top panel). Cu-detected chromatograms of the FTS of mitochondria from 
yeast cells were dominated by a peak corresponding to a mass of 5000 Da; the 
corresponding concentration was ~16 µM. Cu5000 accounted for ~60% of the Cu in the 
FTS and ~20% of Cu in yeast mitochondria. With a mass of 5000 Da, Cu5000 might be 
proteinaceous. The intensity of this species increased 4-fold when the Cu concentration in 
the medium was increased 10-fold. Curiously, the Cu-detected chromatograms of the 
mammalian system did not exhibit Cu5000 or any other peak in 2000–10000 Da region. 
This was similar to the results of our previous study of mouse brain LMM extracts, in 
which no LMM Cu species were reproducibly evident but many HMM Cu species (8–48 
kDa) were observed.158 
For mitochondrial FTSs, the region between 200 and 2000 Da exhibited minor-
intensity peaks with significant preparation-to-preparation variation (Figure III-6, bottom 
panel). At the high sensitive required to observe these peaks, some baseline drift is evident. 
Peaks corresponding to masses of ~300 Da may reflect hydrated Cu ions. The poorer 
reproducibility and low-intensity character of these LMM Cu-based peaks suggest that 
some Cu ions may dissociate from their endogenous complexes during mitochondrial 
isolation, and that the released ions coordinate to various ligands. 
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Cobalt 
The Co-detected chromatograms of mitochondrial FTSs exhibited many peaks 
between 1200 and 300 Da (Figure III-7 and Table III-5), albeit with more batch-to-batch 
variability than for most other metals. The concentration of the dominant peak at 1200 Da 
(Co1200) was 30 nM, 3 orders of magnitude lower than for many other LMM metal species. 
The similar masses of various cobalamins (1300–1700 Da) suggest that Co1200 is a 
cobalamin. FTS from yeast mitochondria exhibited other Co peaks, corresponding to 
masses between 840 and 200 Da, but the batch-to-batch variation in the intensity of these 
peaks was significant. Peaks in the 200 Da region were probably hydrated Co ions. Peaks 
corresponding to masses between 300 and 800 Da were probably not cobalamins as their 
masses were too low; their concentrations were in the nanomolar range. 
Co chromatograms of mammalian samples were similar to each other, except that 
the intensities of the Co peaks in the Jurkat sample were very low. FTSs of mammalian 
mitochondria contained Co1200 as well as another cobalamin (Co1700) with a mass of 1700 
Da. 
 
Molybdenum 
Chromatograms of mammalian mitochondrial FTSs exhibited a single Mo peak 
(Mo730) at 730 Da (Figure III-8 and Table III-5). No Mo species were detected in 
fermenting yeast mitochondrial FTSs. 
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Figure III-7. Cobalt chromatograms of LMM mitochondrial FTSs. 
 
 
 
 
 
Figure III-8. Molybdenum chromatograms of LMM mitochondrial FTSs. Black 
traces are representative of those found in FTSs from yeast mitochondria. M) from mice 
brains, N) from human Jurkat cells, O) from mice livers. 
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Lability of LMM Metal Complexes 
We assessed whether 1,10-phenanthroline (Phen) and bathophenanthroline 
disulfonate (BPS) could chelate the metal ions in the detected complexes. The FTS from 
a batch of yeast mitochondria was subjected to the LC-ICP-MS system, and Fe, Zn, Co, 
Mn, and Cu chromatograms were obtained (Figure III-9, black lines). Fractions containing 
LMM metal complexes were pooled and treated with BPS, but this had little effect. After 
being treated with BPS, Phen, and the reductant dithionite, the same pool exhibited 
chromatograms whose peaks were significantly changed (Figure III-9, red lines). The 
changes were numerous and dramatic, such that further systematic studies are required to 
interpret them. It is clear, however, that the dominant LMM metal complexes in yeast 
mitochondria can be labilized by metal chelators. 
 
Discussion 
In this study, we detected numerous LMM P, S, Mn, Fe, Co, Cu, and Zn 
compounds in mitochondria isolated from yeast and mammalian cells. A LMM Mo 
complex was detected exclusively in mitochondria from mammalian cells. We cataloged 
each and estimated their molecular mass and concentration within the organelle. The 
model of Figure III-10 illustrates the major detected species, including concentrations and 
suggested locations in the organelle. Most of these metal complexes are presumed to be 
in the matrix and used to metalate apo-metalloproteins. Cu5000 in yeast mitochondria and 
Mo730 in mammalian mitochondria may be located in the IMS. Further studies are required  
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Figure III-9. Lability of LMM metal complexes. The FTS from yeast mitochondria were 
subjected to the LC-ICP-MS system. Fe, Zn, Co, Mn, and Cu chromatograms were 
obtained (black lines). Fractions were collected in the two regions which contained the 
major LMM peaks (two pairs of vertical dashed lines). Those fractions were pooled and 
treated with BPS (500 µM final concentration). After 15 min, the solutions were 
centrifuged and half of the supernatant was subjected again to the LC-ICP-MS system. 
The resulting chromatograms were essentially unchanged. The other half of the 
supernatant was treated with 1,10-phenanthroline and freshly prepared dithionite (500 and 
750 µM, respective final concentrations). The solution was centrifuged again and the 
supernatant was subjected to the LC-ICP-MS system. Red lines are the resulting traces. 
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Figure III-10. Model of LMM metal complex speciation in yeast and mammalian 
mitochondria. The sizes of the colored squares represent the relative concentrations of 
various LMM species. Other details are given in the text. 
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to establish their locations, compositions, structures, and biochemical and physiological 
functions. 
We previously detected a single Mn species in yeast mitochondria and proposed 
that it metalated apo-Sod2.113 We now assign this role to Mn1100 despite a slightly lower 
mass. Mammalian mitochondria contain a second Mn enzyme, Type II arginase,178,179 that 
catalyzes the synthesis of ornithine and may regulate the production of NO by nitric oxide 
synthase. An enzyme precursor is imported into the matrix where a signal sequence is 
clipped, and the protein folds and is metalated, perhaps by a second Mn complex in these 
organelles, Mn2000. 
Zn1200 in yeast mitochondria and Zn1200, Zn900, and Zn1500 in mammalian 
mitochondria probably compose the labile Zn pool that metallates various mitochondrial 
Zn proteins.84 High concentrations of mitochondrial Zn inhibit respiration.180 Perhaps 
ferrochelatase installs Zn1200 rather than FeII into protoporphyrin IX.99 Mitochondria from 
neuronal cells contain Zn that can be mobilized and released when the IM is depolarized.43 
Mobilized Zn ions may correspond to one or more detected LMM Zn species. 
Using fluorescence resonance energy transfer-based sensors, Palmer and co-
workers detected labile Zn in mitochondria of HeLa cells.106 McCranor et al.105 used 
human carbonic anhydrase II variants to detect labile Zn in rat mitochondria. Labile Zn 
was detected in mitochondria from mammalian cells using modified GFP fused to 
calmodulin.43,180 Chyan et al.181 used a synthetic fluorescent probe to detect labile Zn in 
prostate cells. When the medium was spiked with 50 µM Zn, the fluorescence intensity of 
the mitochondria in normal cells increased 2.3-fold. 
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We anticipated that the Zn species detected in our study would be the same as those 
detected by fluorescence-based methods. However, if the reported concentration of the 
fluorescence-detected Zn species is accurate, we have not detected them. McCranor et 
al.105 concluded that the concentration of labile Zn in mitochondria isolated from a rat cell 
line was 0.15 pM. Virtually the same concentration was reported for the labile Zn pool in 
mitochondria of HeLa cells.106 These concentrations are 1 billion times lower than our 
estimates for the concentration of Zn1200. Our LC-ICP-MS system simply cannot detect 
picomolar concentrations (1pM Zn = 0.07 ppt) so our ability to detect Zn species implies 
that they are present at concentrations greater than hundreds of picomolar. 
Another consideration is that the collective volume of mitochondria in cells is just 
a few percent of the volume of a yeast cell, suggesting a mitochondrial volume of ~10-15 
L. Within this volume, a concentration of 0.15 pM would correspond to 10-4 molecules of 
labile mitochondrial Zn per cell. This implies that just 1 of every 10000 cells would 
contain mitochondria with a single labile Zn ion, a property that should be easily 
distinguished from that in which all mitochondria in a cell population uniformly fluoresce 
when treated with a sensor. As far as we are aware, there have been no reports of stochastic 
single-molecule fluorescence in these organelles. This implies that each mitochondrion 
contains a sizable number of labile Zn ions, which implies, in turn, a labile Zn 
concentration orders of magnitude higher than reported. 
In contrast, our Zn results are fully consistent with those of Atkinson et al.,84 who 
used LC to detect a LMM cationic Zn pool in the matrix of yeast mitochondria. Their 
reported pool probably corresponds to Zn1200. The Zn ions in their pool migrate through a 
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Sephadex G25 column in accordance with a mass slightly lower than that of vitamin B12 
(1355 Da), within error of the mass of our Zn1200. The size of their Zn pool increases when 
the growth medium is supplemented with Zn, similar to what we observed with Zn1200. 
The Zn species composing their pool is cationic (implying ligands that on average are 
uncharged), resistant to boiling, and inert toward proteinase K digestion (implying that it 
is nonproteinaceous). This species was proposed to metalate numerous Zn enzymes in the 
matrix, including alcohol dehydrogenases, Leu9, and cytochrome c oxidase. Depleting 
this pool (by placing the apo form of a Zn enzyme into the matrix) causes a respiratory 
growth defect, consistent with Zn1200 serving to metalate proteins required for respiration. 
Lutz et al.145 discovered that 1,10-phenanthroline inhibits Fe/S cluster assembly in 
intact mitochondria. Similar results were obtained by Amutha et al.182 and Pandey et al.183 
who speculated that mitochondria must contain a pool of Fe that is used as feedstock for 
Fe/S cluster assembly. Phen was thought to penetrate the matrix and coordinate the pool, 
making it unavailable for Fe/S cluster assembly. Unaware of those results, Holmes-
Hampton et al.144 performed the same experiment in which Phen was added to intact 57Fe-
enriched mitochondria. Using Mössbauer spectroscopy, they discovered a pool of non-
heme high-spin (NHHS) FeII ions that were selectively chelated by phen. When considered 
with the results of Lutz, Amutha, and Pandey, the pool of NHHS FeII ions very likely 
functions as feedstock for Fe/S cluster biosynthesis. The associated Mössbauer parameters 
indicate an FeII species with five or six oxygen and nitrogen donors but no sulfurs. This 
HS FeII(O/N)5-6 species appears to be in equilibrium with a HS FeIII species and with FeIII 
oxyhydroxide nanoparticles.143,144 The concentration of NHHS FeII that constitutes this 
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pool depends on the metabolic state of the cells from which the mitochondria are isolated. 
In fermenting mitochondria, the concentration of the NHHS FeII was ~150 µM, whereas 
in respiring mitochondria, it was much lower. Because the concentrations of respiratory 
complexes are 3 times higher in respiring mitochondria, Morales et al.143 proposed that 
this decline was due to an increased rate of Fe/S cluster assembly (and an invariant rate of 
import of Fe into the pool) under respiration conditions. 
Rauen et al.42 detected a labile Fe pool in mitochondria using rhodamine-based 
fluorescence sensors and estimated a concentration of ~16 µM.142 It is intriguing to 
consider that the same species detected by fluorescence is the NHHS FeII species detected 
by Mössbauer spectroscopy and used for Fe/S cluster assembly. The 10-fold disparity in 
concentration may reflect differences in the cells used or different metabolic conditions. 
In this study, we have detected two LMM Fe complexes in mitochondria, Fe1100 
and Fe580. This contrasts with our previous results in which a single LMM Fe complex 
with a mass of ~3000 Da was detected in soluble extracts of mitochondria isolated113 from 
fermenting yeast cells harvested as they entered postexponential growth. There may have 
been a systematic error in calibrating masses, but we cannot identify any. More likely, 
different Fe species may be present, depending on metabolic conditions or preparation 
methods. 
The collective concentration of Fe1100 and Fe580 in mitochondria was ~100 µM; 
some chromatograms were dominated by one Fe species, while others were dominated by 
the other. Fe1100 and Fe580 appear to be related, as the former transformed into the latter by 
simply incubation of the FTS for 5 days in a refrigerated inert atmosphere. Although much 
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remains to be learned regarding this relationship and the function of these species, we 
tentatively suggest the following model: 
 
 
 
The key feature of this relationship is that the level of Fe/S clusters in the matrix 
inhibits the conversion of Fe1100 to Fe580. During exponential growth, the steady-state level 
of Fe/S clusters is low because the clusters are quickly being installed into various 
apoprotein targets. This relieves the inhibition, such that Fe1100 levels decline and Fe580 
levels rise (as observed). As cell growth declines, the steady-state level of Fe/S clusters 
builds, which strengthens the inhibition of the transforming reaction. Thus, Fe1100 
accumulates and Fe580 declines (as observed). This model must be tested further; it 
currently serves merely to organize our results. The role of Fe1500 in mammalian cells 
remains unknown. 
Curiously, the dominant S, Mn, Zn, and Fe (at high culture density) species in 
fermenting yeast mitochondria all have molecular masses of ~1100 – 1200 Da. One 
interesting possibility is that all of these complexes possess a similar coordination 
environment that includes sulfur as a ligand. Metal glutathione complexes have been 
proposed as trafficking ligands in eukaryotic cells.153,157,184 Conceivably, these metal 
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complexes might be related to [M(SG)4]2-, which would have a mass of ~1300 Da. Further 
studies are required to evaluate this possibility. 
Winge and Cobine reported that 70 – 85% of the Cu in mitochondria is a 
nonproteinaceous species that serves trafficking and/or metallating functions.33,44,66 They 
considered this species (CuL) to be “low-molecular weight,” but it migrates in accordance 
with a 13 kDa globular protein.44 The complex with characteristics most like those of CuL 
is Cu5000. Like that of Cu5000, the concentration of CuL is sensitive to the concentration of 
Cu in the medium; the level of CuL increases 6-fold in cells grown in medium 
supplemented with 500 µM Cu.44,66 One difference is that CuL is found in both yeast and 
mouse liver mitochondria, while we have detected Cu5000 in only yeast mitochondria. 
More of the Cu ions in mammalian mitochondria are in a HMM form, including some Cu 
species with masses near 13 kDa. 
Cu5000 accounted for 22% of the Cu in mitochondria (16 µM out of 71 µM total). 
Morales et al.143 estimated that the concentration of cytochrome c oxidase in fermenting 
yeast mitochondria was ~8 µM, implying ~24 µM Cu (there are three Cu ions per enzyme 
molecule). Combining these two concentrations (16 + 24 = 40 µM) leaves ~30 µM for all 
other Cu-binding proteins in mitochondria, including Sco1/2, Cox17, CuZn Sod1, Ccs1, 
and CuL. CuL has been estimated to represent 85% of the Cu in yeast mitochondria.88 In 
our preparations, this would correspond to 60 µM. The region between 2000 and 200 Da 
was devoid of any peak with an intensity corresponding to anywhere near 60 µM 
(observed peaks are roughly 1/100th of this concentration). 
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Many studies have detected labile Cu in mitochondria, all of which have been 
attributed to CuL. Dodani et al.82 developed a fluorescent sensor (Mito-CS1) that 
selectively targets the mitochondria of HEK293T cells and human fibroblasts where it 
binds a labile CuI species. Yang et al.81 used a custom-designed fluorescent sensor along 
with synchrotron X-ray fluorescence to detect labile Cu in mitochondria. Their data 
indicate a CuI complex with linear or trigonal geometry and primarily sulfur coordination. 
Our experiment with Phen suggests that Cu5000 is labile, raising the possibility that 
the fluorescence-detected labile Cu in mitochondria might arise from Cu5000 rather than 
(or in addition to) CuL. However, the absence of Cu5000 or other LMM Cu species in 
mitochondria from mammalian cells would seem to argue against this possibility. Also 
uncertain is whether Cu5000 (or CuL or some other Cu-trafficking species) is used to 
metalate cytochrome c oxidase. Cu is thought to be imported into the matrix via Pic2, a 
mitochondrial carrier family protein.67 CuL in the matrix has also been suggested to 
metalate the Cu-containing proteins in the IMS,79 but further studies are required to 
establish this. Given the size of Cu5000, transporting it across the IM from the matrix to the 
IMS seems unlikely. The possibility that the Cu used to metalate cytochrome c oxidase 
travels from the cytosol directly to the IMS should be reconsidered. Cu5000 may be just 
small enough to pass through the pores of the OM. However, further studies are needed to 
evaluate these ideas. 
The concentrations of LMM Co species observed here were very low, leading us 
to wonder whether they are physiological. They may correspond to cobalamin degradation 
products, possibly including hydrated Co ions at ~200 Da. Cobalamins are noncovalently 
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attached to proteins, and tiny quantities may have been released during isolation. 
Alternatively, the observed species may be trafficking complexes that metalate methyl-
malonyl-CoA mutase, the only known cobalamin-containing mitochondrial enzyme.119 
Cobalamins are not synthesized by mammalian cells but are imported as vitamin B12. The 
mechanism by which B12 enters mitochondria involves trafficking proteins CblB, CblC, 
and CblD.119  
The presence of a LMM Mo species (Mo730) in mammalian mitochondria and its 
absence in yeast mitochondria are consistent with the presence of mitochondrial 
amidoxime reducing components 1 and 2 (mARC1/2) in mammalian mitochondria and 
the absence of these and any other Mo-containing enzymes in yeast. mARC1/2 are 
molybdopterin-containing proteins found in the OM of mitochondria,185 where they 
catalyze the reduction of NO2- to NO and might be involved in a signaling pathway that 
regulates NADH-dependent hypoxic NO production.186 The mass of Mo730 is within the 
range of molybdopterins (albeit with two pterin coenzymes coordinated). Mo730 may be 
associated with the metalation of mARC1/2. Alternatively, it may reflect a tiny amount of 
a molybdopterin released into solution during mitochondrial isolation. 
We have used the same LC-ICP-MS system to detect LMM metal complexes in 
mouse brain homogenates, including complexes found in mitochondria and other regions 
of the brain.158 At this early stage of investigation, we have focused solely on identifying 
common species. We suggest the following correspondences: P490(brain) ≈ P520(mito), 
S940(brain) ≈ S1100(mito), Fe1720(brain) ≈ Fe1500(mito), Fe510(brain) ≈ Fe580(mito), 
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Zn1760(brain) ≈ Zn1500(mito), Mn2710(brain) ≈ Mn2000(mito), and Mn1270(brain) ≈ 
Mn1100(mito). More work is needed to establish these associations. 
The regulatory mechanisms used to sense the concentrations of these metals in the 
environment and to control the corresponding concentrations in the cytosol and 
mitochondria are not understood. The increased concentrations of particular LMM metal 
complexes when cells were grown on media that contained higher-than-normal 
concentrations of the same metal ion undoubtedly reflects such mechanisms. We suspect 
that (a) the rate of import of metal into the cytosol increases with the increase in nutrient 
metal concentration and (b) the increased cytosolic metal concentration increases the rate 
of import of metal from the cytosol into the mitochondria. Systematic studies are required 
to probe the specific nature of this regulation. 
In summary, we have detected numerous labile LMM metal complexes in 
mitochondria using an LC-ICP-MS approach. The major advantage of this approach, 
relative to the more popular fluorescence-based metal binding probes, is that a portion of 
the detected metal complexes need not be destroyed. Keeping the complexes intact will 
allow for further downstream characterizations. The LC-ICP-MS method also allows 
individual metal complexes to be separated and cataloged such that the vague “pool” 
concept can eventually be discontinued. Also, the area under each chromatography peak 
can be quantified, thereby allowing estimates of the metal complex concentrations within 
cells and organelles. 
The LC-ICP-MS approach does suffer some disadvantages, the most important 
being that cells must be disrupted during the preparation of extracts. Doing so could mix 
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cellular compartments, altering the pH and redox state of the environment in which the 
metal complexes exist. This might, in turn, induce ligand exchange or other reactions, 
resulting in artifacts that could easily be mistaken for bona fide endogenous metal 
complexes. Indeed, some metal complexes that we have detected here might be artifacts. 
Both the LC-ICP-MS approach and the fluorescence-based chelator approach will 
ultimately be required to detect, catalog, identify, and characterize the structure and 
function of these recalcitrant cellular components. Doing so will afford a far more 
sophisticated view of transition metal ion trafficking and regulation in cells, which should, 
in turn, provide significant new insights into metal-associated diseases. 
  
  91 
CHAPTER IV 
AN INTEGRATIVE ANALYSIS OF MRS3DMRS4D SACCHAROMYCES 
CEREVISIAE UNDER IRON-DEFICIENT AND IRON-SUFFICIENT CONDITIONS 
 
Introduction 
Mitochondria have a critical need for iron (Fe) since they are the major site of iron-
sulfur cluster (ISC) biosynthesis in eukaryotic cells and the only site for the Fe-insertion 
step of heme biosynthesis.187,188 Mrs3 and Mrs4 (Mrs3/4) in Saccharomyces cerevisiae are 
homologous mitochondrial inner membrane (IM) proteins that deliver cytosolic Fe (Fecyt) 
into the matrix, presumably for use in both processes.99,132,133,135,189 Mammalian homologs 
of Mrs3/4 are called mitoferrins.130,190,191 The cytosolic Fe species imported by these 
proteins is unknown, but the small, membrane-spanning channel through which the Fe 
must traverse suggests a low-molecular-mass (LMM) coordination complex.132,139,170 
Mössbauer spectra of isolated mitochondria reveal a large pool of non-heme high-
spin (NHHS) FeII complexes in the organelle.144 The overall concentration of Fe in 
mitochondria typically ranges from 400 – 800 µM, while that of the FeII pool ranges from 
60 – 200 µM.143,174 The pool is selectively chelated when isolated mitochondria are treated 
with the membrane-permeable chelator 1,10-phenanthroline.144 The same treatment 
inhibits ISC biosynthesis,145,146,182 suggesting that the pool serves as feedstock for ISC 
assembly and perhaps heme biosynthesis.192 
Size-exclusion chromatograms of LMM mitochondrial flow-through solutions 
(FTSs) from exponentially growing fermenting yeast cells exhibit a single Fe-containing 
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peak corresponding to a mass of ~580 Da.48 The concentration of the so-called “Fe580” 
species is the same order as that of the NHHS FeII pool, raising the possibility that Fe580 
comprises the pool and that this complex is the Fe-containing substrate for ISC (and 
perhaps heme) biosynthesis. Mammalian mitochondrial FTSs also contain Fe580 as well as 
additional LMM Fe species.48 Mitochondrial FTSs from fermenting yeast that were 
harvested under steady-state conditions exhibit a LMM Fe species with a mass of ~1100 
Da. Inexplicably, anaerobic incubation of such a FTS resulted in the disappearance of 
Fe1100 and the appearance of Fe580 in the chromatogram. 
Deleting either MRS3 or MRS4 affords no observable phenotype, indicating that 
the two proteins possess redundant functions.132,189 However, simultaneous deletion of 
both genes, affording the DD strain, yields a slow-growth phenotype in Fe-deficient media. 
Mitochondria isolated from Fe-deficient DD cells contain low concentrations of hemes and 
exhibit low ISC-containing enzyme activities.132,188 DD cells in Fe-sufficient medium grow 
at WT rates, and the activities of ISC-containing enzymes are ca. normal.99,132,135,136,189 
Another phenotype of DD cells grown under both Fe-deficient and Fe-sufficient 
conditions is that they accumulate large amounts of iron relative to WT cells grown under 
the same conditions.132,133,189 Fe accumulation reflects the activation of the iron regulon. 
The occurrence of this under Fe-sufficient conditions indicates Fe dysregulation. The iron 
regulon constitutes 20 – 30 genes, including MRS3/4, that are involved in Fe import, 
trafficking, and regulation. The regulon is activated when WT cells are Fe-starved (e.g., 
when grown in the presence of the FeII chelator BPS) or when ISC biosynthetic activity in 
mitochondria is low.187,188 In WT cells, the Fe regulon is deactivated under Fe-sufficient 
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conditions. However, in ISC-mutant cells (e.g., Yfh1D), the iron regulon is activated 
regardless of the concentration of iron in the medium ([Femed]).193 This results in a massive 
accumulation of FeIII phosphate oxyhydroxide nanoparticles (NP) in mitochondria. Fe also 
accumulates in DD cells but not in mitochondria because the absence of Mrs3/4 impedes 
Fe import into this organelle.132,189 The Fe concentration in DD mitochondria is ca. half of 
that in WT mitochondria.132,189 The presence of Fe in the organelles from DD cells implies 
the existence of alternative Fe import pathways that do not involve Mrs3/4. Alternative 
pathways may involve Rim2, another IM Fe importer that also exchanges pyrimidine 
triphosphate.70,136,194,195 
Vacuoles are acidic organelles in yeast that store and sequester iron and are another 
major organelle involved in Fe trafficking and regulation. Ccc1 is the only known vacuolar 
Fe importer of Fecyt.196 In DD cells, the rate of vacuolar Fe import through Ccc1 is greater 
than in WT cells, despite lower-than-WT concentrations of the Ccc1 protein.133 Li and 
Kaplan hypothesized that Ccc1 activity is higher in DD cells than in WT cells, and they 
proposed that there is a signaling pathway between mitochondria and vacuoles that 
regulates Ccc1 activity.133,195 
In this study, we examined the DD yeast strain using biophysical and bioanalytical 
methods that allow their Fe content to be characterized more extensively than in previous 
studies. These methods included Mössbauer (MB), EPR, and UV-Vis spectroscopies, as 
well as liquid chromatography (LC) monitored by inductively coupled plasma mass 
spectrometry (LC-ICP-MS). In addition, offline ICP-MS was utilized to measure metal 
concentrations of DD cells and isolated mitochondria. Collectively, this study provides 
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new insights into iron trafficking and regulation in yeast. Our mechanism can explain how 
Fe-deficient Mrs3/4 DD cells recover in terms of growth and mitochondrial function when 
grown in Fe-sufficient medium, and how Fe homeostasis remains dysfunctional even 
under such conditions. 
 
Results 
DD and WT cells were grown in minimal medium containing 1, 10, or 40 µM FeIII 
citrate. Some batches that contained 1 µM FeIII citrate were pretreated with 
bathophenanthroline disulfonate (BPS) to chelate endogenous Fe and increase the degree 
of Fe deficiency. We will refer to the cells as DD1 and WT1, DD10 and WT10, DD40 and 
WT40, and DD1BPS and WT1BPS, respectively, where the number refers to the [57Femed] in 
µM and the BPS subscript indicates the presence of the chelator. 57Fe was added to BPS-
treated media to enrich cells with the Mössbauer-active isotope. Glycerol and ethanol were 
exclusively used as nonfermentable carbon sources to force cells to respire. Cells and 
mitochondria were harvested during exponential growth phase. As expected, MRS3 and 
MRS4 were absent in DD cells (see Figure II-2). 
 
The DD Slow-Growth Phenotype 
Exponential growth rates (a) of respiring DD and WT cells grown under Fe-
deficient and Fe-sufficient conditions were obtained from the slopes of ln(OD600) vs. time 
plots (Figure IV-1). Analysis of experimentally determined a values (Table IV-1) revealed 
an Fe-dependent growth defect in yeast cells lacking Mrs3/4. Under Fe-deficient  
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Figure IV-1. Growth rates of WT and DD cells. A, WT1BPS and DD1BPS; B, WT1 and 
DD1; C, WT10 and DD10; D, WT40 and DD40. WT designated as circles and DD 
designated as triangles. Exponential growth rates (a) in units of hr-1 (Table IV-1) are the 
slopes of the plotted lines. Average R2 for these fits was 0.997. 
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Table IV-1. Metal concentrations in whole cells and isolated mitochondria. All 
concentrations are expressed in units of µM. Whole cell concentrations and growth rates 
are averages from two independent experiments (n=2). Mitochondrial metal 
concentrations are from a single preparation for each strain and condition (n=1). 
 
Sample Growth 
Rate (a) 
(hr-1) 
[Fe] 
(µM) 
[Cu] 
(µM) 
[Mn] 
(µM) 
[Zn] 
(µM) 
Whole Cells 
DD1BPS 0.060 360 ± 30 290 ± 10 32 ± 5 240 ± 45 
DD1 0.068 680 ± 70 280 ± 30 25 ± 14 200 ± 50 
DD10 0.150 2160 ± 60 320 ± 40 39 ± 8 190 ± 30 
DD40 0.204 3920 ± 80 320 ± 10 29 ± 7 250 ± 25 
  Ave: 
1780 ± 1600 
Ave: 
300 ± 30 
Ave: 
31 ± 6 
Ave: 
220 ± 30 
      
WT1BPS 0.181 120 ± 20 120 ± 10 21 ± 4 310 ± 65 
WT1 0.184 200 ± 20 140 ± 20 24 ± 6 300 ± 20 
WT10 0.203 480 ± 30 130 ± 10 29 ± 3 315 ± 60 
WT40 0.202 880 ± 70 140 ± 20 31 ± 11 330 ± 60 
  Ave: 
420 ± 340 
Ave: 
130 ± 20 
Ave: 
29 ± 6 
Ave: 
310 ± 10 
Isolated Mitochondria 
DD1  690 63 31 180 
DD40  740 48 34 210 
  Ave: 
720 ± 20 
Ave: 
60 ± 10 
Ave: 
32 ± 2 
Ave: 
200 ± 20 
      
WT1  430 110 22 250 
WT40  690 89 27 320 
  Ave: 
560 ± 130 
Ave: 
100 ± 20 
Ave: 
29 ± 5 
Ave: 
280 ± 50 
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conditions, DD cells grew substantially slower than WT cells, whereas under Fe-sufficient 
conditions, they grew as fast as WT cells. Thus, the “slow-growth” phenotype of DD cells 
was ameliorated as the Fe concentration of the growth medium ([Femed]) increased. 
 
Iron Concentrations in DD Cells and Mitochondria 
To better characterize the Fe-dependent growth phenotype exhibited by DD cells, 
we examined the Fe concentration in DD cells ([Fecell]). [Fecell] in DD cells was 
substantially higher than in WT cells grown on the same medium (Table IV-1). This “iron 
overload” phenotype was observed for all nutrient conditions examined, including those 
for which the growth rates of DD cells were comparable to those of WT cells. Isolated DD 
mitochondria were not Fe-overloaded (Table IV-1), indicating that the excess Fe in DD 
cells had accumulated in non-mitochondrial locations. If mitochondria occupy 25% of the 
volume of respiring DD1 and DD40 cells, then non-mitochondrial regions would contain 
680 and 5000 µM Fe, respectively. Similar calculations for WT1 and WT40 cells afford 
non-mitochondrial Fe concentrations of ca. 120 and 940 µM Fe, respectively. In both WT 
and DD cells, Fe accumulated in non-mitochondrial locations as [Femed] increased, but the 
extent of accumulation in DD cells was ~6 times greater. 
The massive accumulation of Fe in DD cells indicates that the Fe regulon is 
activated under both Fe-deficient and Fe-sufficient conditions. Ironically, Fe-overloaded 
DD cells grown under Fe-sufficient conditions (for which ISC activity is normal) can be 
activated, we reasoned that the vast majority of the accumulated Fe must not be “sensed” 
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by the cell and is not part of Fe regulation. We also reasoned that the concentration of the 
sensed species in Fe-sufficient DD cells, whatever it is, must be below its set-point 
concentration. Thus, we sought to identify an Fe-containing species in the cell that was 
present in sub-WT concentrations in DD cells grown under all [Femed] conditions. 
 
Mössbauer Spectra of Whole Cells and Isolated Mitochondria 
To determine the forms of Fe that accumulate in DD cells and identify the sensed 
Fe species, we employed Mössbauer (MB) spectroscopy. All components and parameters 
used in MB simulations are given in Table IV-2. The low-temperature (5 K) low-field 
(0.05 T) MB spectrum of WT1BPS cells (Figure IV-2E) was dominated by a central 
quadrupole doublet (CD). A minor doublet with parameters typical of NHHS FeII was also 
evident. Both features were simulated above the spectrum (green and blue lines, 
respectively). The CD arises from [Fe4S4]2+ clusters and LS FeII hemes (the two types of 
centers cannot be resolved by MB spectroscopy) (REF). MB spectra of respiring 
mitochondria are dominated by the CD. This situation arises because respiratory 
complexes contain large numbers of ISCs and heme centers, and these complexes are 
highly expressed in respiring cells (Holmes-Hampton 2012). 
We previously assumed that all of the CD intensity in whole cell MB spectra arose 
from mitochondrial ISCs and LS FeII hemes (Holmes Hampton). However, non-
mitochondrial [Fe4S4]2+ clusters, assembled by the CIA (cytosolic iron-sulfur cluster 
assembly system) must contribute to the CD in whole cell MB—the only issue is how 
much it contributes. Our current MB spectra are most consistent assuming that roughly  
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Table IV-2. Summary of Fe percentages and concentrations determined by 
Mössbauer spectroscopy. Parameters for the NHHS FeIII sextet in DD spectra: d = 0.54 
± 0.05 mm/s; DEQ = 0.62 ± 0.08 mm/s; D = 0.3 ± 0.1 mm/s; E/D = 0.29 ± 0.02; h =1.5 ± 
1; Aiso = -220 ± 8 kG; G = 0.77 ± 0.22 mm/s. Parameters for the NHHS FeIII sextet in WT 
spectra: d = 0.56 ± 0.03 mm/s; DEQ = 0.42 ± 0.05 mm/s; D = 0.5 mm/s; E/D = 0.33 ± 0.01; 
h =1.8 ± 0.5; Aiso = -228 ± 3 kG; G = 0.4 mm/s. Central doublet, [d = 0.45 ± 0.01; DEQ = 
1.11 ± 0.05; G = 0.50 ± 0.15]; NHHS FeII doublet, [d = 1.23 ± 0.06; DEQ = 3.07 ± 0.17; G 
= 0.59 ± 0.16]; Heme Doublet, [d = 0.87 ±0.11; DEQ = 2.22 ± 0.04; G= 0.49 ± 0.19], 
[Fe2S2]2+ Doublet [d = 0.30 ± 0.04; DEQ = 0.44 ± 0.07; G = 0.48 ± 0.19], FeIII nanoparticles 
[d = 0.50 ± 0.05; DEQ = 0.50 ± 0.06; G = 0.4 ± 0.04] (all units in mm/s). The sum of all 
percentages of Mössbauer components was forced to 100% but 10% - 15% of spectral 
intensities were typically unaccounted for by these components. 
 
Sample Cells or 
Mitos 
FeIII  
Sextet 
Central 
Doublet 
NHHS FeII 
Doublet 
Heme 
Doublet 
[Fe2S2]2+ 
Doublet 
FeIII 
Nanoparticles 
  %; [µM] %; [µM] %; [µM] %; [µM] %; [µM] %; [µM] 
DD1BPS C 11; 40 25; 90 47; 170 6; 20 --- 11; 40 
DD1 C 50; 340 16; 110 20; 140 3; 20 --- 11; 70 
DD10 C 49; 1060 9; 190 6; 130 5; 110 --- 31; 670 
DD40 C 56; 2190 4; 160 4; 160 3; 120 --- 33; 1290 
        
WT1BPS C 0; 0 69; 84 12; 14 12; 14 7; 8 --- 
WT1 C 39; 78 39; 78 10; 20 4; 8 8; 16 --- 
WT10 C 39; 190 39; 190 11; 50 5; 20 6; 30 --- 
WT40 C 52; 460 25; 220 8; 70 6; 50 9; 80 --- 
        
DD1 M 9; 60 6; 40 8; 60 --- --- 77; 530 
DD40 M 0; 0 63; 475 15; 110 11; 80  --- 10; 75 
        
WT1 M 15; 60 42; 180 18; 80 4; 20 21; 90 --- 
WT40 M 0; 0 57; 390 30; 210 2;10 11;80 --- 
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Figure IV-2. Mössbauer spectra of respiring whole cells. A, DD1BPS; B, DD1; C, DD10; 
D, DD40; E, WT1BPS; F, WT1; G, WT10; H, WT40. Solid lines are simulations for the 
Central Doublet (green), NHHS FeII doublet (blue), vacuolar HS FeIII sextet (purple), FeIII 
oxyhydroxide nanoparticles (gold), [Fe2S2]2+ doublet (teal), and HS FeII heme doublet 
(brown). The temperature was 5 K and an applied field of 0.05 T was applied parallel to 
the gamma rays. The solid red lines are composite simulations assuming the area 
percentages for each component listed in Table IV-2. 
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half of the overall CD intensity in the WT1BPS spectrum is due to non-mitochondrial CIA-
assembled [Fe4S4]2+ clusters. Such a proportion is required to interpret the MB spectra of 
Fe-deficient DD cells (Figure IV-2, A and B). 
The MB spectrum of DD1BPS cells (Figure IV-2A) was dominated by the same two 
doublets, albeit with different relative intensities. The CD was about half as intense as in 
the WT1BPS spectrum, whereas the NHHS FeII doublet was ~5 times more intense. A 
NHHS FeIII sextet may be evident slightly above the DD1BPS spectral baseline. Since the 
MB spectrum of DD1 mitochondria (Figure IV-3A) was largely devoid of the CD, we 
conclude that most ISCs and NHHS FeII species exhibited in the DD1BPS spectrum are 
localized in non-mitochondrial regions of the cell. Conceivably, FeII in the cytosol of 
DD1BPS cells should be partially blocked from flowing into mitochondria because the high-
affinity Mrs3/4 importers are absent and the alternative mitochondrial iron import pathway 
is slow under Fe-deficient conditions. Such a blockage should cause NHHS FeII to 
accumulate in the cytosol of DD1BPS cells as well as a deficiency of ISCs and hemes in 
mitochondria. 
The MB spectrum of WT1 cells (Figure IV-2F) exhibited two major features, 
including the CD and a sextet assigned previously to vacuolar NHHS FeIII (REF). More 
intense vacuolar-Fe sextets are evident in the MB spectrum of WT10 and WT40 cells 
(Figure IV-2, G and H, respectively). A simulation of this component (purple line) was 
shown above the spectrum of Figure IV-2B. Confirming earlier reports,REF the MB 
spectrum of mitochondria isolated from WT1 cells was dominated by the CD (Figure IV- 
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Figure IV-3. Mössbauer spectra of mitochondria isolated from DD and WT cells. A, 
DD1; B, DD40; C, WT1; D, WT40. The temperature was 5 K and an applied field of 0.05 
T was applied parallel to the gamma rays. The solid red lines are composite simulations 
assuming the area percentages for each component listed in Table IV-2. 
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3C). We hypothesize that about half of the CD in the whole cell WT1 spectrum originates 
from mitochondria, with the other half from the CIA. The MB spectrum of WT1 
mitochondria also exhibited a NHHS FeII doublet and a minor sextet suggesting a small 
amount of NHHS FeIII in the organelle. Previous spectra of Fe-deficient WT mitochondria 
also included a semi-resolved doublet due to [Fe2S2]2+ clusters (REF), and such a doublet 
(simulated by the solid teal line above Figure IV-2F) fits nicely into the whole cell WT1 
spectrum. 
The MB spectrum of DD1 cells (Figure IV-2B) was dominated by an intense 
NHHS FeIII sextet, indicating that the vacuoles are essentially filled with Fe under these 
conditions. The intensity of the CD in the DD1 spectrum was lower than in the WT1 
spectrum, while that of the NHHS FeII doublet was higher than in the WT spectrum. Again, 
the absence of Mrs3/4 in Fe-deficient DD cells likely results in the accumulation of Fecyt 
and reduction of mitochondrial ISCs. It is conceivable that elevated levels of Fecyt 
stimulates Ccc1-mediated Fe import into the vacuoles, consistent with this spectrum. The 
central region of the DD1 spectrum was poorly resolved, but the absorption that remained 
after removing known features was a doublet with parameters typical of FeIII 
oxyhydroxide nanoparticles (NP). 
The MB spectrum of mitochondria isolated from DD1 cells also exhibited a doublet 
due to nanoparticles (Figure IV-3A). A low-intensity NHHS FeII doublet was also present, 
but no CD intensity was evident. This indicates that few if any [Fe4S4]2+ clusters and/or 
LS FeII hemes were present in DD1 mitochondria, and it suggests that most of the CD in 
the DD1 whole cell MB spectrum (Figure IV-2B) was due to non-mitochondrial ISCs 
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assembled by the CIA. Similarly, the strong intensity of NHHS FeII doublet in the DD1 
whole cell spectrum is incompatible with NHHS FeII species being located in DD1 
mitochondria (too little is present in the mitochondrial spectrum to make a significant 
contribution to the NHHS FeII doublet in the whole cell spectrum). These results reinforce 
our hypothesis that FeII accumulates in the cytosol of DD1 cells. This increase in Fecyt 
should induce Fe import into vacuoles, and indeed the concentration of vacuolar FeIII in 
DD1 cells is 4 times that in WT1 cells. The majority of Fe in DD1 mitochondria is present 
as NP with few ISCs. The presence of some CD intensity in the whole cell DD1 MB 
spectrum suggests that cytosolic ISC assembly (CIA) is functioning in DD mutant cells 
grown under Fe-deficient conditions. Although DD1 cells were Fe-overloaded relative to 
WT1 cells, DD1 mitochondria contained about the same concentration of Fe as in WT1 
mitochondria. Thus, the additional iron that flowed into DD1 cells did not localize to the 
mitochondria but rather accumulated in the cytosol and vacuoles. 
The WT10 cell spectrum (Figure IV-2G) was dominated by the CD, due mainly to 
mitochondrial respiration-related proteins, and by the sextet due to vacuolar FeIII. Minor 
doublets due to HS FeII hemes and NHHS FeII species were evident. A simulation of the 
HS FeII heme doublet (solid brown line) was displayed above this spectrum. The 
corresponding DD10 whole cell spectrum (Figure IV-2C) was far more intense, reflecting 
a higher Fe concentration in the cell (Table IV-1). It was dominated by intense sextet and 
NP doublets. The composite simulation of the DD10 spectrum included intensity due to 
the CD, but this doublet was not well resolved which made quantification difficult. 
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The MB spectrum of WT40 cells (Figure IV-2H) was similar to that of WT10, 
except that the sextet was more intense and the CD was less well resolved. The spectrum 
of mitochondria isolated from WT40 cells (Figure IV-3D) exhibited a strong CD and 
NHHS FeII doublet. The spectrum is generally consistent with previous reports (REF), but 
the intensity of the NHHS FeII doublet is more intense than in previous MB spectra of 
respiring mitochondria (REF). We previously reported that the size of the NHHS FeII pool 
was smaller in respiring mitochondria than in the organelle from fermenting cells; 
however, the NHHS FeII doublet in current respiring samples is about as intense as in 
fermenting cells. 
The MB spectrum of DD40 cells (Figure IV-2D) was nearly identical to that of 
DD10 cells, again indicating the accumulation of NP and NHHS FeIII. Surprisingly, the 
spectrum of DD40 mitochondria (Figure IV-3B) was devoid of nanoparticles but rather 
exhibited an intense CD. Thus, the nanoparticles and NHHS FeIII in DD40 cells must be in 
a non-mitochondrial location. The spectrum of DD40 mitochondria also exhibited 
significant intensity due to the NHHS FeII pool (and perhaps some HS FeII hemes), but 
only about half as intense as in the WT40 mitochondria spectrum (Figure IV-3D). We 
conclude that DD40 mitochondria have returned to a healthy state. On the other hand, 
DD40 cells accumulated excessive amounts of Fe, implying that the Fe regulon was 
activated even though DD40 mitochondria exhibited a CD with about the same intensity 
as in WT mitochondria. This was puzzling because the Fe regulon is, by consensus, 
considered to be regulated by the ISC activity in mitochondria, with defective ISC activity 
activating the Fe regulon. Here, the ISC level is normal, yet the Fe regulon is activated. 
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We hypothesize that the slow-growth phenotype of DD1 cells is due to the absence of 
respiratory complexes (i.e., CD) in mitochondria, whereas the WT growth rate of DD40 
cells is due to their presence. How this transformation occurred simply by increasing 
[Femed] is a puzzle, as is the reason why the cells continued to be Fe dysregulated even 
though the ISC levels were normal. We investigated these puzzles further using our 
subsidiary techniques, UV-Vis and EPR spectroscopies. 
 
UV-Vis and EPR Investigations 
UV-Vis spectra of mitochondria isolated from WT1 and WT40 cells (Figure IV-4, 
A and C, respectively) exhibited a Soret band at ~400 nm as well as a and b bands in the 
500 – 620 nm region as is characteristic of FeII heme centers associated with mitochondrial 
cytochromes a, b, and c.197 Both spectra exhibited distinct absorption peaks with similar 
intensities located at ~605, ~565, and ~550 nm that correspond to the a bands of heme a, 
b, and c, respectively. The UV-Vis spectrum of DD40 mitochondria (Figure IV-4D) 
showed similar heme features, albeit with about half of WT intensity. Mitochondria from 
DD1 cells (Figure IV-4B) was devoid of such features. This indicates that mitochondrial 
hemes were not synthesized in DD cells grown under Fe-deficient conditions but were 
synthesized by such cells under Fe-sufficient conditions. 
Low temperature X-band EPR spectra of DD and WT whole cells are shown in 
Figure IV-5, A – H. All spectra in the g = 2 region were dominated by a hyperfine split 
signal due to mononuclear S = 5/2 MnII species. This signal has been observed previously 
in EPR spectra of yeast cells where it was shown to arise from most of the Mn in the cell. 
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Figure IV-4. UV-Vis spectra of mitochondria isolated from respiring WT and DD 
cells. A, WT1; B, DD1; C, WT40; D, DD40. Solutions of isolated mitochondria were 
packed under anaerobic conditions into EPR tubes by centrifugation, and the volume of 
packed organelles in each sample was determined. Packed mitochondria were 
diluted 1:1 with 1xSH buffer (pH= 7.4) and transferred into 2 mm pathlength quartz 
cuvettes. Cuvettes were sealed with a rubber septum, removed from the glove box, and 
spectra were immediately collected at RT. 
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Figure IV-5. X-band EPR spectra of respiring DD and WT cells. A, DD1BPS; B, DD1; 
C, DD10; D, DD40; E, WT1BPS; F, WT1; G, WT10, and H, WT40. Temperatures in A, C, 
E, and G were 10 K while that in others was 4.2 K; intensities were temperature-adjusted 
to allow comparison. Other EPR parameters: average microwave frequency, 9.373 ± 0.003 
GHz; microwave power, 0.2 mW; modulation amplitude, 10 G; Gain, 1000; conversion 
time, 0.3 sec. Displayed intensities on the left were adjusted as indicated for ease of 
viewing. None of the spectra on the right side was adjusted, allowing intensities to be 
directly compared. 
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The presence or absence of Mrs3/4 did not influence the shape or intensity of this signal. 
Superimposed on the Mn-based signal was an isotropic signal at g = 2.00, present 
in all spectra and with similar intensities. We cannot assign this signal to a particular S = 
1/2 species in the cell, as there are many candidates. There were no g = 1.94 type signals 
from S = 1/2 [Fe2S2]1+ or [Fe4S4]1+ clusters in the spectrum. Since such cluster types are 
present in these cells (as evidenced by the CD in MB spectra), the vast majority of such 
clusters (in exponentially growing cells) are in the oxidized S = 0 [Fe2S2]2+ and [Fe4S4]2+ 
states. Similarly, there were no EPR signals from LS FeIII hemes, suggesting that the 
majority of such centers are in the reduced FeII state. Some WT EPR spectra exhibited 
low-intensity signals between g= 4 – 6 (minor features between 1000 – 1300 G), which 
have been previously assigned to the Heme a3:CuB site of cytochrome oxidase with S = 
5/2 FeIIIa3 and S = 0 CuIB. These signals were less obvious in spectra of DD cells because 
the g = 4.3 signal intensity dominated. 
The most prominent signal in the low-field region (high g-value) is at g = 4.3 (and 
minor features at ca. g = 9.6) arising from high-spin S = 5/2 FeIII species with rhombicity 
parameter E/D ~1/3. This signal arises from vacuolar FeIII (REF). As expected, its intensity 
in WT cells increased as [Femed] increased, consistent with increasing amounts of cellular 
Fe being stored in the vacuoles. The intensities of the g = 4.3 signal exhibited by DD cells 
were substantially higher than those exhibited by comparable WT cells, consistent with 
the differences observed in MB spectra. The most intense g = 4.3 signal was from the 
DD40 cells (n=1), which we defined as 100%. The average intensities of the DD10 (n = 3), 
DD1 (n = 4), DD1BPS (n = 4), WT40 (n = 1), WT10 (n = 2), WT1 (n = 2), and WT1BPS (n 
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= 4) was 53% ± 19%, 34% ± 16%, 2% ± 0.2%, 8%, 14% ± 5%, 9% ± 2, and 0%, 
respectively. These data confirm that DD cells contain substantially more vacuolar FeIII 
than comparable WT cells, which is consistent with the MB spectra given above. 
 
LC-ICP-MS of DD Mitochondrial FTSs 
We initially hypothesized that Fe580 passes as an intact complex from the cytosol, 
through Mrs3/4, and into the mitochondrial matrix. Thus, we expected to observe Fe580 in 
FTSs of WT1 and WT40 mitochondria, but not in DD1 and DD40 samples. Fe580 was 
indeed observed in FTSs of WT1 and WT40 mitochondrial extracts (Figure IV-6, A and 
C, respectively), and it was not observed, as expected, in DD1 extracts (Figure IV-6B; two 
independent trials are shown). Unexpectedly, Fe580 was observed in the DD40 trace (Figure 
IV-6D), albeit with a weaker intensity than in the WT40 trace sample, indicating a lower 
concentration. Quantification of areas indicate an [Fe580] concentration of 180 µM in 
WT40 mitochondria and 100 µM in DD40 mitochondria. The presence of Fe580 in DD40 
mitochondria supports the idea that DD40 mitochondria have recovered to a healthy state 
under Fe-sufficient conditions. The trace of DD1 FTS exhibited two very weak LMM Fe 
peaks, at ~2700 and ~2100 Da. These species are characteristic of oxidized mitochondria 
and presumably have no physiological role. 
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Figure IV-6. Iron chromatograms of LMM FTSs prepared from WT and DD 
mitochondrial extracts. A, WT1; B, DD1 (two independent trials); C, WT40; D, DD40. 
Trace intensities were adjusted as shown for ease of viewing. Chromatograms were 
obtained by using an online LC-ICP-MS system and detecting for 57Fe. 
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Electrospray Ionization Mass Spectrometry (ESI-MS) of Fe580 
We have obtained preliminary ESI-MS spectra of the Fe580-containing fraction 
collected from an LC-ICP-MS chromatogram (Figure IV-7, top panel). The FTS used for 
this experiment was from mitochondria isolated from WT40 cells grown on medium 
containing an approximate 1:1 molar ratio of 56Fe:57Fe. ICP-MS detector responses for 
57Fe (red) and 56Fe (black) confirm that Fe580 was enriched in both isotopes. The ESI-MS 
spectrum of the Fe580-containing fraction exhibited two peak pairs at {664.46 and 665.46 
amu} and {685.39 and 686.39 amu} (Figure IV-7B, inset). We consider both pairs as Fe580 
candidates, and they raise the possibility that Fe580 consists of two species that co-migrate 
on our LC column. None of these peak pairs was present in spectra of column fractions 
before (Figure IV-7A) or after (Figure IV-7C) the Fe580 peak. We regard this as progress 
in identifying Fe580 but realize that further work is required to establish its mass and 
chemical composition. 
 
Relationship Between Fe1100 and Fe580 
Mitochondria harvested from fermenting yeast cells during postexponential 
(stationary-state) growth phase were shown to contain a LMM Fe species called Fe1100 
rather than Fe580 in Chapter III of this dissertation. Curiously, allowing FTSs from 
mitochondrial extracts to incubate in a refrigerated anaerobic glove box for a few days 
resulted in the conversion of Fe1100 ® Fe580. The same transformation occurred in our 
current studies involving respiring yeast cells. One batch of WT mitochondria was 
harvested at an OD600 ~1.2 (typically we harvest at OD600 = 0.8), which is typically the  
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Figure IV-7. Electrospray ionization mass spectrometry of Fe580-containing LC 
fractions. Top Panel: LC trace of FTS from isolated mitochondrial extract obtained from 
cells grown on medium with an approximate 1:1 molar ratio of 56Fe:57Fe. The dashed lines 
and double-arrow lines indicate where fractions were obtained. The buffer was 20 mM 
(NH4)2CO3, pH 8.5. Bottom Panels: A, ESI-MS of the LC fraction before the Fe580-
containing fraction; B, the Fe580-containing fraction; C, the LC fraction after the Fe580-
containing fraction. Inset in B shows a close-up of the peaks associated with the candidate 
Fe580 species. 
  114 
OD at which cells are transitioning from exponential to stationary state. The resulting LC-
ICP-MS trace of the FTS from mitochondria isolated from these cells was dominated by 
Fe1100 (Figure IV-8A); some Fe580 was evident. After incubation for 5 days, the same FTS 
exhibited a strong Fe580 peak but no Fe1100 peak (Figure IV-8B). Corresponding P and S 
traces are shown (Figure IV-8, B and C, respectively). This indicates that the two LMM 
Fe species are related—the simplest explanation being that Fe1100 is a dimer of Fe580. The 
associated P and S traces show that neither P or S peaks comigrate with either Fe peak. 
We conclude that Fe1100 and Fe580 do not contain P or S atoms; this suggests that the donor 
atoms to the Fe ions are O and or N. 
 
Effect of Mrs3/4 Deletion on Other Metals 
Although the focus of this study was on iron, copper trafficking and regulation also 
seems to have been affected by deleting Mrs3/4. The average Cu concentration in DD cells 
was ca. double that in WT cells (Table IV-1), regardless of [Femed]. In contrast, the average 
Cu concentration in DD mitochondria was about half of that in WT mitochondria. This 
suggests that Cu is dysregulated in DD mitochondria, and that a deficiency of Cu in DD 
mitochondria either increases Cu import into the cell or decreases Cu export. Such effects 
were not observed for Zn or Mn (Table IV-1); the cellular and mitochondrial 
concentrations of these metals were unaffected by [Femed] or deletion of Mrs3/4. 
LMM Cu, Mn, and Zn chromatograms (Figure IV-9 – Figure IV-11) of FTSs from 
mitochondria isolated from respiring WT and DD cells exhibited the same LMM species 
as with fermenting cells (REF), including Cu5000, Mn1100, and Zn1200. Cu5000 LC peaks were  
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Figure IV-8. Relationship between Fe1100 and Fe580. 56Fe, 34S, and 31P detection of FTSs 
from mitochondria harvested from WT40 cells harvested as cells were transitioning to 
stationary state: Traces A, C, and E were of fresh FTSs detected by Fe, P, and S. Traces 
B, D, and F detected the same respective elements in the same FTS but after a 5-day 
incubation inside a refrigerated N2-atmosphere glove box. 
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Figure IV-9. Copper chromatograms of LMM FTSs prepared from WT and DD 
mitochondrial extracts. A, WT1; B, WT40; C, DD1; D, DD1 (n=2); E, DD40. 
Chromatograms were collected simultaneously with the Fe traces shown in Figure IV-6. 
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Figure IV-10. Manganese chromatograms of LMM FTSs prepared from WT and DD 
mitochondrial extracts. A, WT1; B, WT40; C, DD1; D, DD1 (n=2); E, DD40. 
Chromatograms were collected simultaneously with the Fe traces shown in Figure IV-6. 
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Figure IV-11. Zinc chromatograms of LMM FTSs prepared from WT and DD 
mitochondrial extracts. A, WT1; B, WT40; C, DD1; D, DD1 (n=2); E, DD40. 
Chromatograms were collected simultaneously with the Fe traces shown in Figure IV-6. 
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less intense in DD traces compared to those in WT, consistent with the lower Cu 
concentration in DD mitochondria. Low-intensity Cu species with masses between 200 – 
3000 Da were present in some traces, but they were not reproducible and could be artifacts 
generated during sample preparation. 
 
Discussion 
In this study, we have used an integrative biophysical and bioanalytical approach 
to explain the phenotype of yeast cells in which Mrs3 and Mrs4, the high-affinity Fe 
importers on the mitochondrial IM, have both been deleted. Under Fe-deficient conditions, 
DD cells grew slowly relative to WT cells, whereas Fe-sufficient DD cells grew at WT 
rates. Our results suggested that under Fe-deficiency, Fe import into mitochondria was too 
slow to prevent O2 from diffusing into the matrix. This was because the size of the NHHS 
FeII pool in the matrix was insufficient to generate normal WT levels of ISCs, hemes, and 
thus respiratory complexes. Under such conditions, much of the O2 that diffused across 
the IM penetrated the matrix to react with the FeII pool to generate nanoparticles and ROS. 
This resulted in a vicious cycle in which decreasing mitochondrial FeII concentrations 
limited the assembly of ISC/hemes and thus respiratory complexes. Conceivably, the 
membrane potential was also affected. In the case of Fe-sufficiency, the process reversed. 
A higher concentration of cytosolic Fe stimulated Fe import into mitochondria, increasing 
the size of the NHHS FeII pool and the concentration of respiratory complexes. Normal 
respiratory activity returns, rendering the matrix anaerobic and reestablishing membrane 
potential. 
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To explain why the iron regulon was activated in DD cells under Fe-sufficient 
conditions, even though such cells grew at normal rates and their mitochondria were 
generally healthy, we sought to identify the intracellular Fe species that serves as a sensor 
for the iron regulon. The concentration of such a sensor in both Fe-deficient and Fe-
sufficient DD cells should be below its normal WT concentration—such a situation is 
required to maintain the Fe regulon in the activated state. ISC assembly activity is thought 
to generate the sensor X-S for regulation.187,188 However, the proxy previously used to 
estimate this activity, namely the intensity of the CD in MB spectra was normal in DD40 
cells.198 We considered Fecyt as a possible sensor, but its concentration was actually higher 
than normal in DD40 cells. Nanoparticles were excluded for the same reason. The only 
observed Fe species that fulfilled the requirement was the mitochondrial NHHS FeII pool, 
the concentration of which was lower-than-WT in both DD1 and DD40 mitochondria. 
Thus, we propose that the size of this pool controls the Fe regulon activity. This does not 
preclude the use of X-S as a sensor; e.g., both may be involved in assembling Fe2S2 
clusters that are involved in downstream signaling. Our proposal is also consistent with 
previous interpretations of Fe dysregulation in ISC-mutant strains (e.g. Yfh1D) because in 
such mutants, both ISC and FeII pool levels are reduced.187,188 
Our results provide strong evidence that the mitochondrial NHHS FeII pool in 
exponentially growing yeast mitochondria is composed exclusively of Fe580. This species 
was also observed in mammalian mitochondria. The Fe concentration associated with the 
FeII pool in yeast ranges from 60 - 200 µM (Table IV-2), depending on strain and [Femed]. 
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We previously estimated the concentration of Fe580 in mitochondria to be in the same 
ballpark, ca. 100 µM.48 
We are pursuing the chemical composition of Fe580, and report here preliminary 
ESI-MS data in which two candidate species have been detected, at m/z = 665 and 686 
Da. Further studies are underway to connect these species unambiguously to Fe580 and to 
obtain and analyze MS/MS fragmentation patterns. Our current LC-ICP-MS results 
suggest that the irons of Fe580 and Fe1100 are coordinated mainly by O and/or N donor 
ligands, not by S. In support of this, the DEQ and d of the NHHS FeII doublet in MB spectra 
of isolated mitochondria (3.07 mm/s and 1.23 mm/s, respectively) are typical of FeII 
complexes with 4 – 6 O and 0 – 2 N donor ligands. 
Fe580 may also be present in the cytosol and pass as an intact complex through the 
channels of Mrs3/4 into the matrix. Alternatively, the endogenous ligands of Fecyt might 
dissociate, FeII ions may flow through the Mrs3/4 channels (handed off from one protein-
based ligand to the next), and then other ligands localized within the matrix may 
coordinate the entering FeII ions as they emerge from the channels into this space. Our 
results impact this discussion. If “intact-channeling” occurred and if Fe580 were 
exclusively imported via Mrs3/4 channels, then Fe580 should not have been present in the 
FTS of DD40 mitochondria (but it was). If Fe580 also channeled through the alternative 
import transporter intact, then Fe580 should have been present in the FTS of DD1 
mitochondria (but it was not). One caveat is that the loss of membrane potential in DD1 
mitochondria might prevent Fe580 import through the alternative importer; thus, the intact 
channeling mechanism could still be operative. However, we contend with this possibility 
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for a couple reasons. First, we find it unlikely that both Mrs3/4 and the alternative Fe 
import pathway mediate transport for the same LMM complex. Moreover, the requirement 
for a specific Fe complex is belied by the ability of simple (hexaaqua) FeII ions to 
successfully enter isolated mitochondria.99 On the other hand, such a lack of specificity is 
expected for the unwrapping/rewrapping mechanism. Accordingly, whether Fe580 
assembles in the matrix upon exiting the channel depends on the metabolic state of the 
organelle. Fe580 may not form if the matrix is devoid of the appropriate ligand(s), or if the 
matrix is not sufficiently anaerobic, or if the mitochondria lack sufficient membrane 
potential. Under stationary-state conditions, the ligand environment may be different than 
under exponential growth conditions (e.g., the concentrations of potential coordinating 
ligands might vary) such that Fe1100 (or Fe2700 or Fe2100) forms instead. Overall, these 
considerations support the unwrapping/rewrapping mechanism. 
In 2001, Lutz et al. discovered that ISC assembly in isolated mitochondria was 
inhibited following treatment with the IM-permeable chelator 1,10-phenanthroline 
(Phen).145 A few years later, Amutha et al. and Pandey et al. concluded from similar studies 
that mitochondria must contain an endogenous pool of Fe that is used as feedstock for ISC 
(and heme) biosynthesis.146,182 In 2010, Holmes-Hampton et al. discovered that the NHHS 
FeII pool observed in MB spectra of isolated mitochondria was selectively coordinated by 
Phen, suggesting that this is the pool proposed previously.144 Here we confirm and extend 
our previous studies to show that Fe580 composes this pool and that this LMM Fe complex 
serves as feedstock for ISC and likely heme biosynthesis. Also of significance is that Fe 
does not accumulate in mitochondria in which YFH1, MRS3, and MRS4 are all 
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deleted.99,132,135,189 This strongly suggests that the Fe accumulating within mitochondria of 
Friedreich’s ataxia patients passes through the human orthologs of Mrs3/4, namely 
mitoferrins 1/2. The Fe oxidation state in nanoparticles is FeIII, whereas that for the 
mitochondrial Fe pool is FeII. This implies that Fe580 is an FeII complex that reacts with O2 
(in Friedreich’s Ataxia) to generate the nanoparticle accumulation phenotype. NP are often 
described as “toxic” to the cell, since ROS is formed in association with the nanoparticles. 
However, from a chemical perspective, nanoparticles should be benign. It is more likely 
that the reaction of FeII580 with O2 is deleterious. Thus, the reaction chemistry of Fe580 may 
be of critical importance for understanding the pathophysiology of Friedreich’s ataxia.199 
Our results confirm previous results that DD cells contain twice as much Cu as WT 
cells,133 indicating Cu dysregulation. Since DD mitochondria contain substantially less Cu 
than WT mitochondria, we conclude that a mitochondrial Cu deficiency stimulates cellular 
Cu import. This can also explain the increased sensitivity of Cu in DD cells.133 The non-
mitochondrial location of the accumulated cellular Cu is unknown but cytosol and 
vacuoles are reasonable possibilities.  
The majority of Cu in mitochondria is thought to be in the form of a labile 
nonproteinaceous Cu species called CuL.44,68,69 CuL is thought to be imported from the 
cytosol through IM proteins Pic2 and Mrs3, stored in the matrix, and then trafficked back 
into the IMS through an unidentified Cu exporter on the IM. CuL is touted as being LMM, 
but it was reported to have a mass of ~13,000 Da, which is simply too large to pass through 
channels of an IM protein. Cu5000 is similarly too large to enter the matrix via channels in 
an IM protein, and so it cannot be CuL (also, it represents only ~20% of mitochondrial Cu, 
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whereas CuL reportedly represents ~90% of yeast mitochondrial Cu). FTSs of 
mitochondrial extracts from fermenting yeast contain no reproducibly observed LMM Cu 
species with a mass <3000 Da48 and here we show the same, only for respiring yeast 
mitochondria. In brief, our evidence strongly suggests that CuL (defined as a LMM Cu 
complex that resides in the matrix and represents > 80% of mitochondrial Cu) does not 
exist. Our evidence indicates that Cu5000 does exist (at least in yeast mitochondria), but we 
have no further insight into its physiological role. We have hypothesized that Cu5000 is 
present in the IMS where so much mitochondrial Cu chemistry occurs,48,192 but further 
studies are needed to establish this. We agree that the decline in the concentration of 
mitochondrial Cu (and Cu5000) in DD cells along with the increase of cellular Cu in these 
cells is consistent with Mrs3 functioning as an IM Cu importer, as concluded,68 but this 
decline may also arise from secondary effects. 
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CHAPTER V 
CONCLUSIONS AND FUTURE WORK 
 
Conclusions 
The principal objective of this dissertation was to investigate chemical-level details 
of the mitochondrial labile iron pool (LIP) by integrating knowledge obtained from several 
different analyses, including Mössbauer, EPR, and UV-Vis spectroscopies, as well as LC-
ICP-MS. Within the past few decades, there has been a major push in the field to 
characterize mitochondrial labile metal pools (LMPs) using fluorescence-based sensors. 
A key advantage of these sensors is that they can traverse into cells and organelles without 
destroying them, which makes them particularly useful for detecting and monitoring 
endogenous metal pools within their biological milieu. However, this chelator-based 
strategy is fundamentally limited in its ability to chemically characterize LMPs since the 
endogenous metal complexes of interest are destroyed during their detection. Thus, the 
LMPs have largely remained uncharacterized. To solve this problem, we applied an 
integrative biophysical and bioanalytical approach relying on various spectroscopic 
methods in conjunction with a novel LC-ICP-MS system to characterize the mitochondrial 
LIP. 
The LIP is defined as a pool of LMM iron complexes that are weakly coordinated 
by unknown ligands. The study described in Chapter III established that mitochondria 
contain a diverse array of LMM metal complexes (< 10 kDa). This was determined via 
the application of an LC-ICP-MS system, consisting of size-exclusion chromatography 
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(SEC) columns interfaced online to an ICP-MS. In collaboration with Dr. Sean 
McCormick (Ferris State University), isolated mitochondria from WT fermenting yeast 
cells, human Jurkat cells, and mouse brain and liver were evaluated for the presence of 
LMM metal species. To prevent the degradation of such species via redox and ligand-
exchange reactions during chromatographic workup, the entire LC component of the 
system was contained in a refrigerated N2-atmosphere glove box. Another useful feature 
of this setup is that it includes a flow splitter at the bottom of the SEC columns that directs 
a portion of eluate to a fraction collector (located inside the glove box) for further analysis. 
This separations-based approach was utilized previously to detect and identify several 
LMM metal complexes in biological systems.ref  
Using the LC-ICP-MS system described above, we detected numerous 
unidentified LMM P, S, Mn, Fe, Co, Cu, Zn, and Mo species (< 10 kDa) in yeast and 
mammalian mitochondrial extracts. While most of these LMM species were reproducibly 
observed in both yeast and mammalian mitochondria, the latter typically contained a few 
additional species. In this study, concentrations and approximate molecular masses of all 
LMM species were estimated. Treatment with chelators revealed that dominant LMM 
metal complexes were labile. 
Fermenting wild-type (WT) mitochondria contained either of two major LMM iron 
complexes with approximate masses of 1100 and 580 Da (referred to as Fe1100 and Fe580, 
respectively). Mitochondria harvested in exponential growth phase (OD600 ~0.8) 
contained Fe580, whereas mitochondria harvested during postexponential growth, or 
stationary-state (OD600 ~1.2 – 1.6), exhibited Fe1100. After 5 days of anaerobic incubation 
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in a refrigerated glove box, Fe1100 converted into Fe580, suggesting a relationship between 
these two LMM Fe species.  
The concentration of Fe580 in yeast mitochondria was ~100 µM, which is consistent 
with previous concentration estimates of the mitochondrial labile iron pool.ref Moreover, 
increasing the [Femed] yielded an increase in the mitochondrial concentration of Fe580 
(other metals were unaffected). Mammalian mitochondria also contained Fe1100 and Fe580 
along with a 1500 Da species (Fe1500). Taken together, this strongly suggests that Fe580 is 
one of the predominant LMM complexes composing the mitochondrial LIP. Thus, we 
hypothesized that Fe580 is imported into the matrix (via Mrs3/4), where it serves as 
feedstock for iron-sulfur cluster (ISC) assembly, heme biosynthesis, or the metalation of 
mitochondrial Fe-containing proteins and enzymes. 
In Chapter IV we characterized a yeast strain lacking the mitochondrial Fe 
importers Mrs3/4 with Mössbauer, EPR, and UV-Vis spectroscopies, as well as the LC-
ICP-MS system. This work was done in collaboration with a fellow graduate student in 
the Lindahl Lab, Mr. Joshua Wofford (Texas A&M University), who analyzed the 
Mössbauer and EPR spectra. We hypothesized that the LIP is markedly reduced in 
mitochondria isolated from Mrs3/4-deficient (DD) cells. Based on the findings in Chapter 
III, we expected that Fe580 would be diminished or absent in DD cells. Since Mrs3/4 
constitute the high-affinity Fe import pathway (i.e., they mediate mitochondrial Fe uptake 
when Fecyt levels are low), we grew DD cells on Fe-deficient and Fe-sufficient conditions. 
Thus, we expected to observe a substantial decrease in mitochondrial Fe species (e.g., 
ISCs, hemes, and the LIP) in the DD strain under Fe-deficient conditions. Conversely, such 
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mitochondrial Fe species should be comparable in Fe-sufficient DD cells due to alternative 
low-affinity Fe import pathways. 
Respiring DD cells exhibited an Fe-dependent “slow-growth” phenotype under Fe-
deficient conditions. To elucidate this DD slow-growth phenotype, we examined 
intracellular Fe concentrations, the results of which revealed that DD cells accumulated 
excessive amounts of Fe regardless of [Femed] and that the excess Fe accumulated in non-
mitochondrial locations. Additionally, iron overload in DD cells under Fe-sufficient 
conditions reflected Fe dysregulation. We hypothesized that this dysregulation was due to 
reduced levels of some Fe species that is “sensed” by cellular regulatory systems. 
We searched for this intracellular “sensed” Fe species via Mössbauer (MB) 
spectroscopy. Fe-deficient DD cells accumulated NHHS FeII (presumably in the cytosol) 
and contained decreased levels of central doublet ([Fe4S4]2+ clusters and LS FeII hemes), 
which is mostly associated with the respiratory complexes in mitochondria and serve as 
an indicator of the health status of mitochondria. Fe-sufficient DD cells accumulated FeIII 
oxyhydroxide nanoparticles (NP) and NHHS FeIII in non-mitochondrial locations, most 
likely in the vacuoles and possibly in the cytosol. The accumulation of vacuolar HS FeIII 
in DD cells was further corroborated via EPR analysis. 
While Fe-deficient DD mitochondria accumulated NP and were devoid of CD, Fe-
sufficient DD mitochondria exhibited WT levels of CD, indicating that they have 
recovered to a healthy state under such conditions. This observation was reinforced in UV-
Vis spectra, which revealed that mitochondrial FeII heme levels were drastically reduced 
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in Fe-deficient DD mitochondria but roughly normal under Fe-sufficient conditions, again 
supporting the idea that Fe-sufficient DD mitochondria have recovered to a healthy status. 
Interestingly, the NHHS FeII pool was substantially reduced in Fe-sufficient DD 
mitochondria relative to its levels in WT. Integrating the results obtained from MB, EPR, 
and UV-Vis analyses, we proposed that (a) the “slow-growth” phenotype exhibited by 
respiring Fe-deficient DD mitochondria was due to diminished levels of mitochondrial 
respiratory complexes and (b) the Fe dysregulation (i.e., “iron overload phenotype”) in 
Fe-sufficient DD cells resulted from reduced levels of the NHHS FeII pool in mitochondria. 
As expected, Fe580 was present in Fe-deficient WT mitochondria but not in Fe-
deficient DD mitochondria. Surprisingly, Fe580 was present in both Fe-sufficient WT and 
DD mitochondria as well as Fe-deficient WT mitochondria. Moreover, the mitochondrial 
concentration of Fe580 was markedly reduced in Fe-sufficient DD mitochondria, in 
agreement with the decrease in the NHHS FeII pool observed in MB spectra. Therefore, 
we propose that the NHHS FeII pool is composed predominantly of the LMM Fe complex, 
Fe580, which is also found in fermenting yeast as well as mammalian mitochondria 
(Chapter III). Furthermore, we propose that Fe580 is a key component of cellular Fe 
regulation and homeostasis. Preliminary ESI-MS data yielded two candidate species with 
determined masses of 664.46 and 685.39 Da, suggesting the intriguing possibility that 
perhaps Fe580 consists of two distinct Fe complexes. 
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Future Work 
Characterizing the chemical composition and biological function of the 
mitochondrial LIP has significant pathophysiological implications, given the multitude of 
diseases linked to defective iron homeostasis. Such diseases are often characterized by 
either iron overload or iron deficiency phenotypes. For example, Friedreich’s ataxia and 
X-linked sideroblastic anemia are both marked by mitochondrial iron overload.200,201 To 
elucidate the role of the LIP in health and disease states, future studies will be required to 
fully characterize its chemical nature. 
One of the major conclusions presented in this dissertation is that the mitochondrial 
LIP is predominantly composed of Fe580. Therefore, chemical characterization of Fe580 is 
of utmost importance. The first major step in structurally characterizing the Fe580 complex 
will be to determine its accurate molecular mass. We obtained preliminary ESI-MS results 
that revealed two candidate masses of Fe580 (664.46 and 685.39 Da) in the study described 
in Chapter IV, but further work is required before these masses can be accepted. This 
experiment should be repeated and will involve enriching Fe580 with an equimolar ratio of 
56Fe:57Fe and observing this ratio in the ESI-MS peak intensities of Fe580-containing 
fractions. The mass of Fe580 will be established by the presence of peak pairs separated by 
1 amu with equal intensities (corresponding with a 1:1 enrichment ratio) in Fe580-
containing fractions and the absence of such features in negative controls.  
More detailed ESI-MS studies along with MS/MS fragmentation analysis could 
provide chemical insights into the endogenous ligands bound to the iron. An example of 
the former would be to treat Fe580 with a chelator and observe how this affects the resulting 
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ESI-MS spectrum. Treatment of isolated Fe580 with 1,10-phenanthroline (phen) should 
show the disappearance of ESI-MS peaks with m/z = 664.46 and 685.39 and the 
emergence of a peak corresponding to the Fe-phenanthroline complex, [Fe(phen)3]2+. 
Comparison with a background spectrum of Fe580 (no phen treatment), would allow 
common features to be subtracted, which could reveal peaks corresponding to the 
dissociated endogenous ligands of Fe580. 
Once the mass of Fe580 has been established, studies will be aimed at determining 
its chemical structure. This will likely require the application of multiple techniques such 
as NMR, EPR, XAS, and perhaps even Mössbauer spectroscopy. One issue is that these 
methods likely require increased amounts and purer samples of Fe580. One way to increase 
the amount of Fe580 for downstream structural analysis might require simply combining 
several Fe580-containing fractions from multiple mitochondrial isolations. In Chapter III, 
it was observed that increasing the [Femed] increases the mitochondrial concentration of 
Fe580. Thus, growing cells on higher [Femed] would yield a larger quantity of Fe580. 
Increasing the purity of Fe580 could be achieved by adding another dimension of LC 
separation following gel filtration. Injecting Fe580-containing fractions onto a hydrophobic 
interaction liquid chromatography (HILIC) column or an ion-exchange column could 
remove additional contaminants that might hinder structural analysis.  
With sufficient amounts of purified Fe580, analysis by NMR spectroscopy could 
potentially identify the structures of endogenous Fe580 ligands. One problem, however, is 
that because iron is paramagnetic it leads to extreme line broadening in spectra, making 
them difficult to interpret. One way to possibly overcome this, would be to collect spectra 
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of Fe580-containing samples before and after treatment with a chelator. This type of 
analysis could potentially reveal signatures corresponding to the ligands associated with 
Fe580. 
Another important research endeavor involves elucidating the biological functions 
of Fe580. Based on our integrative analysis, we proposed that the mitochondrial 
concentration of Fe580 can modulate cellular Fe homeostasis and regulation. Additionally, 
we proposed that Fe580 is utilized as a substrate in ISC assembly and perhaps heme 
biosynthesis. Future studies will be needed to substantiate both of these functions, which 
can be accomplished using the strategy employed in Chapter IV. Here, we investigated 
the mitochondrial LIP using biophysical spectroscopic methods, LC-ICP-MS, and a 
genetic mutant yeast strain lacking mitochondrial Fe importers Mrs3/4. This approach can 
be used to evaluate if there is, in fact, Fe dysregulation in mutant yeast strains that are 
expected to have diminished levels of Fe580 in mitochondria. For example, Rim2 is thought 
to serve as a low-affinity mitochondrial Fe importer. It would be interesting to examine a 
triple deletion mutant yeast strain lacking Rim2 and Mrs3/4. In this case, triple deletion 
mitochondria should be largely devoid of Fe580, leading to cellular Fe dysregulation and 
an Fe overload phenotype. The role of Fe580 in ISC and heme biosynthesis could be 
investigated with an Mrs3/4-overexpression strain. In this case, mitochondria would be 
expected to contain elevated amounts of Fe580, which would yield increased levels of ISCs 
and hemes. 
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